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SUMMARY
This study (2 x 2 factor design) describes an investigation into the physiological interaction
between the peripheral endocrine and cytokine systems after the organism has been
exposed to psychological stress. An in vivo rodent model with two interventions was used:
(1) mild psychological stress (immobilisation for 2 hours per day, for 4 days); (2) an anti-
interleukin (IL)-6-antibody injection. Thirty-nine male Wi star rats were divided into 4 groups
and given either the antibody (CA, control antibody) or stress (lP, immobilisation placebo),
or both (lA, immobilisation antibody), or neither (CP, control placebo). Antibody and
placebo (saline) were injected intraperitoneally. Differences between groups for the
following parameters were determined in blood or metabolic tissues, viz. skeletal muscle
and liver:
1) corticosterone concentrations,
2) glucocorticoid receptor (GR) binding capacity and
3) activities of metabolic enzymes, tyrosine aminotransferase (TAT) and
glutamine synthetase (GS).
Groups lP and lA showed a significant loss in body mass (CP vs. lP, p<O.01; CA vs. lA,
p<O.001), indicating a main effect of stress. The corticosterone concentrations of only
group lP were significantly elevated compared to that of group CP (CP vs. lP, p<O.01),
again indicating a main effect of stress. All three intervention groups (CA, lP, lA) had
decreased GR binding capacity, with group lA showing a statistically greater decrease (CP
vs. CA, p<O.05; lP vs. lA, p<O.01; CP vs. lP, p<O.001; CA vs. lA, p<O.001), indicating main
effects of stress and antibody treatment. In groups lP and lA increased activities of both
enzymes (TAT and GS) were measured (main effect of stress), with lA again showing the
greatest statistically significant increase for both enzymes. The liver tissue displayed
greater sensitivity to the stress and antibody regimes. This study provides the first
conclusive in vivo evidence for IL-6 modulation of glucocorticoid action in peripheral
tissues in response to mild psychological stress.
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OPSOMMING
Hierdie studie (met 'n 2 X 2 faktorontwerp) beskryf 'n ondersoek oor die fisiologiese
interaksie tussen die perifere endokrien- en sitokiensisteme in organismes blootgestel aan
psigologiese stres. Daar word gebruik gemaak van 'n in vivo-rotmodel met twee
intervensies: (1) matige psigologiese stres (immobilisering vir 2 uur per dag vir 4 dae); (2)
'n anti-interleukin (IL)-6-antiliggaam inspuiting. Nege-en-dertig manlike Wistar rotte is in
vier groepe verdeel en het óf antiliggaam (CA, antiliggaam kontrole), óf stres (lP,
immobilisasie placebo), óf beide stres en antiliggaam (lA, immobilisasie antiliggaam) of
geen behandeling ontvang (CP, placebo kontrole). Die antiliggaam- en placebo (sout-
oplossing)-inspuitings is intraperitoneaal toegedien. Verskille tussen die groepe van die
volgende parameters, in metaboliese weefsels (skeletspier en lewer), was bepaal:
1) kortikosteroon konsentrasies,
2) glukokortikoïed reseptor (GR) bindingskapasiteit en
3) aktiwiteite van die metaboliese ensieme, tirosien aminotransferase (TAT)
en glutamien sintetase (GS).
Groepe lP en lA het 'n beduidende afname in gewig getoon (CP vs. lP, p<O.01;CA vs. lA,
p<O.001), wat 'n hoof-effek van stres aandui. Die kortikosteroon konsentrasies van slegs
lP het beduidend toegeneem in vergelyking met CP (CP vs. lP, p<O.01),wat weereens 'n
hoof-effek van stres aandui. AI drie intervensiegroepe (CA, lP, lA) het verlaagte GR
bindingskapasiteit getoon, met lA wat 'n groot statistiese afname getoon het (CP vs. CA,
p<O.05; lP vs. lA, p<O.01;CP vs. lP, p<O.001;CA vs. lA, p<O.001),wat hoof-effekte van
beide stres en antiliggaam-behandeling aandui. In groepe lP and lA is toenames in beide
ensiemaktiwiteitvlakke (TAT en GS ensieme) getoon (hoof-effek van stres), met lA wat
weereens die grootste toename gewys het. Die lewer het ook verhoogde sensitiwiteit tot
die stres- en antiliggaamregimente. Hierdie studie lewer die eerste daadwerklike in vivo
bewyse vir IL-6 modulering van glukokortikoïedaksie in perifere weefsels na reaksie op
psigologiese stres.
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IV
" ... we have learned that the body possesses a complex machinery of checks and balances.
These are remarkably effective in adjusting ourselves to virtually anything that can happen to
us in life. But often this machinery does not work perfectly: sometimes our responses are too
weak, so that they do not offer adequate protection; at other times they are too strong, so that
we actually hurt ourselves by our own excessive reactions to stress."
Hans Selye (1956), 'The stress of life'
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1CHAPTER 1 INTRODUCTION, HISTORICALOVERVIEW
AND AIMS
1.1 Introduction to stress and the adrenals
Hans Selye, once a medical doctor, is known as the "father of stress". Even
though he never received a Nobel Prize for his ground-breaking achievements
(despite being nominated several times), he single-handedly pioneered research
on stress since the late 1930s.We owe the modern awareness of stress to him,
as he first suggested that stress is a "state manifested by the specific syndrome
which consists of all the non-specifically induced changes within a biologic
system" (Selye, 1956). His research focused specifically on the physiological
responses to stress.
Selye exposed rats to various types of stress for various durations before they
were finally sacrificed and dissected. These dissections showed that stress
causes 1) enlargement of the adrenal cortex, 2) atrophy of the thymus, spleen,
lymph nodes and other lymphatic structures and 3) development of deep
bleeding ulcers in the stomach and duodenum (Selye, 1956). These observations
clearly indicated that 3 apparently separate systems were all affected by the
common cause, "stress". Nevertheless, the adrenal gland and glucocorticoids
(GCs) were the initial focus of stress research.
The experiments of Selye led to a classification of the progressive nature of
stress effects on the body, particularly its influence on the adrenal glands. The
"General Adaptation Syndrome" was described as having the following three
stages:
• The 'Alarm Reaction' - characterized by surprise and anxiety, and
generally considered to activate the 'fight or flight' reaction (Selye 1956).
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2The adrenal glands secrete the hormones epinephrine, norepinephrine
and hydrocortisone (cortisol) during this stage (Selye, 1956).
• The 'Resistance Phase' - with continued exposure to stress, the body
prepares for future stress and adapts its response to the stressor(s). This
phase is characterized by adrenal hypertrophy as well as a more rapid
return to the resting state after an acute stressor (Selye, 1956).
• The 'Exhaustion Phase' - the adrenal glands can no longer meet the
demands placed on them due to prolonged stress (Selye, 1956).
This endocrine research laid the basis for subsequent biochemical,
neurophysiological and, more recently, psychoneuroimmunological (PNI) stress
research. PNI is considered a fairly new concept (Benowitz, 1996), but is itself
based on a long history of integrative research on the GCs and the immune
system.
Due to our multidisciplinary biochemical and physiological interests, we sought to
investigate the stress-sensitive interaction between GCs and the cytokine system
in an in vivo rat model.
1.2 Glucocorticoids and the immunesystem
Although Selye was one of the most prolific researchers of GC physiology, he
turned out to be wrong about some critical aspects (Sapolsky et aI., 2000). He
claimed that GC excess could cause arthritis, allergies and collagen-related
disorders (Selye, 1956). However, potent anti-inflammatory GC actions were
discovered which did not fit into the paradigm that GCs cause illnesses (Hench et
aI., 1949; reviewed by Munck et aI., 1984). Rather, GCs play a role in the
regulation of the immune system. The following paragraphs will briefly outline the
historical development of our current concept that not only do GCs communicate
with the immune system, but the immune system also communicates with the
endocrine stress axis.
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3Actually, it was as early as 1855 that Thomas Addison observed that a patient
with adrenal insufficiency had an excess of circulating lymphocytes (Addison,
1855). In 1924, Jaffe removed the adrenal glands ('suprarenalectomy') and
observed a subsequent hypertrophy of the thymus (Jaffe, 1924). The thymus is
the organ responsible for manufacturing mature lymphocytes (Vander, 2001). It is
with this background that Selye performed his famous studies published in 1925.
Following his results, it was realized that no matter what the nature of the injury
or stressful insult, the laboratory animals developed enlarged adrenal glands and
an involuted thymus (Selye, 1956). These early studies clearly suggested a close
relationship between adrenal gland physiology and immune capacity.
The first direct proof that adrenal GC secretion plays a significant role in
regulating immune processes was provided between 1936 and 1949 by the
Nobel Prize winners, Kendall, Hench and Reichstein. They isolated the active
component secreted by the adrenal cortex (cortisone) and demonstrated its
ability to suppress inflammation (Hench et ai., 1949). However, it was only in the
1980's that Munck and Guyre interpreted this relationship more clearly: the
increased secretion of GCs during stress is important in preventing the
inflammatory and immune response systems from over-reacting (Munck and
Guyre, 1986; Munck et ai., 1984). Munck et al. proposed in their 1984-review that
"(a) the physiological function of stress-induced increases in GC levels is to
protect not against the source of stress itself, but against the normal defense
reactions that are activated by stress; and (b) the GCs accomplish this function
by turning off those defense reactions, thus preventing them from overshooting
and themselves threatening homeostasis". Although these contributions of
Munck et al. are regarded as very significant, the efforts of Marius Tausk in 1951
were not recognized. According to Sapolsky et ai., Tausk published a similar idea
to that of Munck and his colleagues in a pharmaceutical company's periodical
(Sapolsky et ai., 2000). Tausk illustrated his idea by comparing stress to a fire
and the role of GCs to that of preventing water damage rather than putting out
the fire (Tausk, 1951). In 1989, a subsequent study was able to link continuous
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4immune inflammatory responses (in streptococcal cell wall arthritis-susceptible
Lewis rats) more definitively to inadequate counter-regulation of GC output
(Sternberg et al., 1989). Therefore, although GCs are indirectly involved (notably
by the absence of its main actions), they do not cause immune diseases as
suggested almost 60 years before by Selye.
Studies showing immunosuppression by GCs resulted in widespread use of GC-
based therapies for autoimmune and inflammatory diseases (for a recent review
see Turnbull and Rivier, 1999). However, it was the pioneering work of
Besedovsky, del Rey, Sorkin and colleagues that provided the real mechanisms
for the physiological role of GCs in preventing overactivity of immune reactions
(Besedovsky et al. 1979; Del Rey et al. 1984). Their contributions actually laid
the foundation for Munck's review (Munck et al. 1984). These researchers
showed that the influence of GCs on immune processes is much more complex
than a generalized suppression of immune activity. Besedovsky et al. suggested
that immune activity itself also influences GC secretion (Besedovsky et al.,
1975). This and other studies suggested the existence of an immune-
neuroendocrine regulatory feedback mechanism in which immune cells indirectly
limit their own activity by secreting molecules that stimulate the secretion of
adrenal GCs (Besedovsky et al., 1975; Besedovsky et al., 1981). This concept is
now called the 'bi-directional communication' between the immune and endocrine
systems - Blalock and colleagues were the first to describe molecules actually
responsible for such bi-directional communication (Blalock et al. 1985, Blalock,
1989; Weigent & Blalock, 1987).
1.3 Glucocorticoid-inducible factors
Several studies identified factors released under physiological stress that also
seemed to be capable of communicating with the HPA axis. For example,
Besedovsky et al. showed in 1985 that stimulated lymphocytes produce a
"glucocorticoid increasing factor" (GIF) that increases plasma ACTH and
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5corticosterone levels in rats and that hypophysectomy prevented this response
(Besedovsky et al. 1985). This GIF was later identified as interleukin-1 (IL-1) (a
cytokine - see Chapter 2, section 2.5). GIF which was shown to cause fever via
signalling of the central nervous system (CNS) after systemic invasion by
pathogens (for reviews see Atkins, 1960; Kluger, 1991). IL-1 plays an important
endogenous role in regulating the HPA axis during viral disease (Silvermann et
aI., 2005). Also, it was realized that 'extrahypothalamic' corticotropin-releasing
factors, released by injured tissue, were also cytokines (Lymangrover and
Brodish, 1973; Brodish, 1977a; Brodish, 1977b).
The monokines, IL-1 and interleukin-6 (IL-6, also known as hepatocyte-
stimulating factor), stimulate adrenocorticotrophic hormone (ACTH) secretion
(Woloski et al. 1985). (The monokines are part of the cytokine family - see
Chapter 2, section 2.5, for further explanation). Definitive evidence was provided
by Besedovsky et aI., who demonstrated that, (a) in normal mice, systemic
administration of monocyte-derived or recombinant IL-1 increases plasma ACTH
and GC concentrations; and (b) in rats, neutralization of endogenous IL-1 inhibits
the GC response to experimental viral infection (Besedovsky et al. 1986). These
and other studies provided evidence that the immunoregulatory cytokines are a
key, centrally active link between the immune and neuroendocrine systems
(Besedovsky et al. 1986; Healy et al. 1983; McGillis et al. 1985; Woloski et al.
1985).
Further studies implicated the hypothalamus as the particular central site at
which the HPA axis response to IL-1 is mediated. The ability to increase the
secretory activity of the HPA axis is a fundamental biological property of several
other cytokines as well: various interleukins, tumor necrosis factors, chemokines,
hematopoietins, interferons, growth and neurotrophic factors (Turnbull and Rivier,
1999). In this respect, it is also important to note that cytokines stimulate the
secretion of other cytokines, e.g. IL-1 potently stimulates the secretion of IL-6
(Libert et aI., 1990; Nietfeld et aI., 1990; Shalaby et aI., 1989; Tosato and Jones,
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61990). Ruzek et al. suggested that IL-6 is actually the circulating mediator of IL-1
actions (Ruzek et al., 1997). Hence, recent and current research is focusing
more and more on the role of IL-6 (e.g. Vanden Berghe et al., 2000; Samuelsson
et al., 2004).
Cytokine up-regulation of the hypothalamic-pituitary-adrenal (HPA) axis may
occur not only during infection, inflammation and trauma, but also during periods
of psychological stress unrelated to the presence of disease or tissue damage
(Turnbull and Rivier, 1999). The role of IL-6 in the adrenal and target tissue
response to psychological stress is the focus of this thesis.
1.4 Corticosteroid receptors
The mobilisation of GCs, whether through direct activation of the HPA-axis during
stress or through indirect activation by cytokines, acutely affects a large variety of
tissues. A popular approach to studying the molecular mechanisms whereby
GCs exert their effects, is to study the GC receptors (GRs) (Arriza et al., 1987;
Evans, 1988; Funder et al., 1988; Whorwood et al., 1992; Rupprecht et al., 1993;
Trapp et a/., 1994; Listwak et al., 1996; Korn et al., 1998; Yudt and Cidlowski,
2002; Almawi & Melemedjian, 2002; Schacke et a/., 2004). Two types of GRs
exist, the Type 1 (mineralocorticoid receptor, MR) and Type 2 (the classical
glucocorticoid receptor, GR) (Listwak et a/., 1996).
The actions of corticosteroids (e.g. aldosterone, corticosterone and cortisol) are
mediated by both MRs and GRs, which function as hormone-activated
transcription factors that regulate target gene expression (Evans, 1988). In the
CNS the MRs and GRs mediate both the feedback inhibition of HPA axis-activity
by cortisol or corticosterone as well as feedforward functions such as regulation
of circadian rhythms (Martin & Reichlin, 1987; De Kloet, 1991). There is a higher
affinity between cortisol and MR than between cortisol and GR (Listwak et al.,
1996), therefore occupancy of the MR in the hippocampus occurs with lower
Stellenbosch University http://scholar.sun.ac.za
7levels of cortisol (associated with non-stress conditions or general homeostasis).
This appears to set the activation level of the HPA axis, whereas occupancy of
the GR during stress-associated conditions with higher levels of cortisol results in
feedback inhibition of the HPA axis (Listwak et ai., 1996). The importance hereof
lies in the realization that the MR and GR have different roles, although both via
cortisol, in regulation of the HPA axis, which results in a coordinated control of
homeostasis for this axis (De Kloet, 1991).
Peripherally, the MR is expressed in high concentrations in the kidneys and large
intestine, where it mediates the regulation of water and electrolyte balance by
aldosterone (Listwak et ai., 1996). GRs are constitutively expressed in most
tissues throughout the body, but GR density varies under different physiological
conditions (Okret et aI., 1991). Selectivity of both types of receptors for either
cortisol or aldosterone is controlled by the expression of t t-B-hydroxysterold
dehydrogenase (11-P-HSD), an enzyme that exists in two isoforms, 11-p-HSD-
type 1 and 2 (Arnold et ai., 2003). The former isoform is primarily a reductase, in
vivo, and forms active cortisol from inactive cortisone, whereas the latter is an
oxidase that catalyzes the inactivation of cortisol and therbey renders MR-
specificity for aldosterone (Baker, 2003b; Arnold et aI., 2003). It follows that
differential expression of the 11-p-HSD isoforms determines the specific tissue
responses to either aldosterone or cortisol (or corticosterone), via the MR or the
GR.
The major interest of this thesis pertains to the peripheral activity of GR after
psychological stress. Cortisol (humans) or corticosterone (rats) is present in the
circulation in much higher concentrations than aldosterone (Baker, 2003a) and
the scope of this thesis is to investigate the peripheral activity of GR in major
metabolic tissues such as liver and muscle. Also, 11-p-HSD-type 1 activity has
been found in the liver, which indicates a more specific role for GR in the liver
(De Kloet et ai., 1998).
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8Further interest in the GR is heightened by the ongoing controversy regarding
whether or not GR expression is increased or decreased after increases in the
GC concentrations during stressful situations. Many researchers have found that
an increase in GCs lead to down-regulation of GRs during exposure to stress (for
a summary, see discussion of AI-Mohaisen et aI, 2000), possibly providing a
mechanism whereby the effects of prolonged GC action is limited. Other
researchers, in contrast, found increases in GR number and activity (AI-
Mohaisen et aI., 2000; Sun et aI., 2002). This discrepancy is discussed in
Chapter 5.
The function of the GR is to bind to GC response elements (GRE) in the
promoters of target genes, thereby regulating the expression of many enzymes
and proteins (see examples in section 1.5 and review by Newton, 2000). As a
primary feature, GCs, via the GR, induce gluconeogenesis in the liver as a
means to increase the availability of glucose for energy production during stress
(Trenkle, 1981; Sun et aI., 1998). GCs, via GR, also induce mobilisation of
substrates for gluconeogenesis from e.g. muscle tissue (Salway, 1994). In this
respect, our interest is focused on the activity of GR in the cytosol of the
metabolic target tissues, muscle and liver. Cytosolic GR translocates to the
nucleus and regulates the expression of genes (for a detailed discussion on
these mechanisms, see Chapter 2). Examples of GC-inducible enzymes are
discussed below.
1.5 Glucocorticoid-inducible enzymes
Glucocorticoids induce gluconeogenesis via the transcriptional up-regulation of
specific enzymes involved in amino acid metabolism in various metabolic tissues.
Our interest in the peripheral effects of glucocorticoids was investigated by
focusing on the activities of two well-known GC-inducible metabolic enzymes,
viz. glutamine synthetase (GS) and tyrosine aminotransferase (TAT).
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9The genes that encode for these enzymes are rendered GC-inducible by the
existence of GREs in their promoter regions. It is a well-known fact that TAT and
GS activities increase during stress (AI-Mohaisen et aI., 2000; Vats et aI., 1999).
The metabolic purpose of such up-regulation lies in the subsequent alteration of
amino acid metabolism, which ultimately serves to supply amino acids that are
used in energy production by other organs, especially the liver (Salway, 1994). In
addition, GS and TAT represent two of the most well-known GC-inducible
enzymes. Despite this, no evidence exists which proves a relationship between
their activities, especially after exposure to psychological stress. Our focus,
therefore, is to separately investigate the activities of these enzymes during
psychological stress and to subsequently determine whether there is any
correlation between TAT and GS function.
1.6 Classificationof GCfunction
In accordance with a recent classification (Sapolsky et el., 2000), one can
distinguish between two classes of GC actions: modulating actions (actual GC
actions resulting in the effects that alter the organism's responses to the stressor
and include the permissive, suppressive and stimulating GC actions) and
preparative actions (actions that do not affect the immediate response to a
stressor but modulate the organism's response to a subsequent stressor i.e. the
initial stress response results in an adaptation possibly at the level of gene
expression). The preparative actions of this classification correlate with Selye's
'resistance phase' of the general adaptation syndrome (section 1.1). In essence,
the body adapts to the stressor and prepares for future stressful encounters.
Brief explanations of modulating GC actions are (Sapolsky et aI., 2000):
~ Permissive GC actions are exerted by GCs present before the stressor
and therefore prime the defense mechanisms by which an organism
responds to stress. I interpret this to mean that a certain range of
corticosterone/cortisol concentrations is maintained in circulation
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('baseline' levels) to ensure a certain amount of activated receptors in
tissues for baseline modulation of gene activity.
);> Suppressive GC actions are attributable to the stress-induced rise in GC
levels. These actions have an onset from about an hour or more after
the onset of the stressor. These actions represent stress-activated
defense reactions and prevent the stress system from overshooting.
);> Stimulating GC actions are also attributable to the stress-induced rise in
GC levels. These actions, too, have an onset from about an hour or
more after the onset of the stressor. They are the reverse of the above-
described suppressive actions because they enhance the effects of the
first wave of hormonal responses to stress (i.e. the catecholamines, see
Chapter 2). Permissive and stimulating GC actions are collectively
referred to as helping to mediate the stress response.
Whether or not a target tissue (or protein) responds suppressively or stimulatory
is not well understood, which provides impetus for our current research interests.
1.7 Current issues
Tracing the historical development of our understanding of stress, cytokines,
GCs and GRs has highlighted, in particular, our improved understanding of their
roles in the HPA-axis response but not the subsequent tissue responses. The
multiple mechanisms whereby corticosteroids and cytokines exert their effects on
the body of the mammalian organism are still not completely understood, hence
the importance of establishing these mechanisms more clearly. The close
bidirectional communication between the endocrine and cytokine systems has
previously mainly been studied in models of infection or fever (e.g. Busbridge et
aI., 1990; Dunn, 1993; Dunn and Vickers, 1994; Ruzek et aI., 1997). Very few in
vivo studies have investigated the effect of psychological stress on cytokines in
conjunction with endocrine parameters, particularly not with inclusion of receptor
analyses at the level of target tissues other than the CNS.
Stellenbosch University http://scholar.sun.ac.za
11
Recent evidence suggests that many cells other than immune cells also
synthesize and are responsive to cytokines. This is attributed to interaction at a
molecular level between the activated GR and transcription factors or enzymes
(e.g. nuclear factor (NF)-xB and cyclooxygenase (COX-2)) that modulate the
expression of cytokines and other immune parameters (Rivest, 2001).
Recently, blocking the effects of one or another cytokine in the cascade of the
inflammatory response has become possible by using various models, e.g.
knockout mice models (e.g. Xing et a/., 1998), or administration of antiserum or
antibody, e.g. antibodies directed against IL-6 (Arruda et a/., 2000; Marby et a/.,
2001). Very few studies using blocking models have assessed GR responses.
Such studies can illuminate our understanding of the complex response to stress
or illness.
1.8 Hypothesisandaims
During psychological stress, IL-1a and -~ are the main cytokines released from
the hypothalamus. As a result, IL-6 release into circulation (from e.g. immune
cells) is stimulated, which is responsible for a host of peripheral effects.
Specifically, we hypothesize (based on previous in vitro work) that IL-6 is
responsible for modulation of GC action in circulation as well as in peripheral
tissue, and that this IL-6 modulation of GC action is essential in preventing the
stress-induced GC response from exerting deleterious metabolic effects.
Thus, the aim of this study was to investigate the effects of blocking IL-6, in vivo,
during psychological stress on:
• two parameters of stress, namely, body mass and circulating
corticosterone levels;
• GR activity levels by measuring GR binding capacity in the liver and
muscle;
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• the activities of two GC-inducible enzymes, GS and TAT, in liver and
muscle.
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CHAPTER 2 LITERATURE REVIEW
2.1 The stress response
2.1.1 Stressors
A stressor has been defined as any intrinsic or extrinsic threat or challenge to the
homeostasis of an organism (Chrousos & Gold, 1992). Thus, stress itself can be
defined as a state of disrupted homeostasis to which the organism adapts by
employing a host of physical or mental reactions (adaptive responses) that
attempt to counteract the effects of the stressors in order to reestablish
homeostasis (Chrousos & Gold, 1992). The adaptive responses are further
divided into general (non-specific) and specific responses (Chrousos & Gold,
1992). Typical stressors include conditions such as, for example, hunger or
fasting, viral or bacterial infections, inflammation, exercise, emotional and
psychological stress. The response to stress is typically characterised by
surprise, anxiety and alarm (Selye, 1956).
Stressful experiences can either be acute or chronic. Acute stressors are
perceived as intensely stressful experiences that may last for a few seconds to a
few hours. In contrast, chronic stressors are stressful experiences that persist for
a few days or even months and may be less intense. Due to the increase in the
prevalence of many long-term diseases, the focus of the last two decades of
research shifted from the study of acute effects to the study of the effects of long-
term chronic stressors. The current understanding, as explained by Tsigos and
Chrousos, is that chronic activation of the stress system is likely to lead to
diseases already described by Selye in 1936 (Tsigos and Chrousos, 2002; Selye,
1936).
Stellenbosch University http://scholar.sun.ac.za
14
In attempts to study and clarify the mechanisms underlying stress responses,
researchers have used many different models of stressors, including caloric
restriction, tissue injury, sepsis, electroshock, endotoxin treatment, exposure to
novel environments, conditioned aversive stimuli, physical restraint and
immobilisation stress (Zhou et ai., 1993; Gursoy et ai., 2001; Turnbull & Rivier,
1999). Some models are severe, whereas others are mild. In addition, the
duration that stress is applied in the various models, or even in the same model,
may differ substantially. This, in part, depends on whether the interests of the
researchers are in the physiological or psychological responses to stress. Other
factors that influence the chosen duration of stress exposure may include
whether or not the researchers are interested in the early adaptive response or
effects of long-term exposure. Immobilisation in rats is known as an inducer of
psychological stress and downstream physiological adaptations have been
documented, hence the use of this model for the purpose of this study (AI-
Mohaisen et ai., 2000; Gursoy et ai., 2001). The term "chronic immobilisation
stress" has been used to describe exposure lasting as briefly as e.g. 7 days
(Aguilera et ai., 1996) and as long as e.g. 2 months (Hu et ai., 2000). Although
the rationale is similar, the model we employ differs in severity from traditional
methods of restraint stress (for details see Reinhardt et aI., 1995) and could
therefore be considered as a model of milder stress.
In the following sub-sections, I will review the stress response: firstly, regarding
its function; and finally, by discussing the two main pathways of response.
2. 1. 1. 1 Function of the stress response
As an essential tool for survival, the stress response functions to re-establish and
preserve homeostasis by activating central and peripheral responses for adaptive
purposes (Chrousos & Gold, 1992). During the stress response, the central
neural pathways (see section 2.1.1.2) mediate functions such as arousal,
vigilance, alertness, cognition, focused attention and appropriate aggression;
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with simultaneous inhibition of feeding and reproductive urges (Chrousos & Gold,
1992). The acute peripheral changes include a shift in metabolism and
redirection of oxygen and nutrients to the central nervous system and the
stressed body site(s) (Chrousos & Gold, 1992). The peripheral changes include
increases in cardiovascular tone (that lead to elevations in blood pressure and
heart rate), increases in respiratory rate, gluconeogenesis and lipolysis thus
promoting enhanced availability of vital substrates (Chrousos & Gold, 1992). The
adaptive responses include a peripherally mediated restraint of growth and
reproduction, both of which preserve energy, so that available energy can be
used more efficiently in other areas of the body.
One major effect of the stress response is the release of glucocorticoids (the
classical 'stress hormones') from the adrenal glands, as mediated through
activation of the HPA axis (sections 2.1.1.2 and 2.2). As mentioned in Chapter 1,
Tausk compared stress to a fire and the role of glucocorticoids to that of
preventing water damage rather than putting out the fire (Tausk, 1951). Munck et
a/., in their frequently quoted review, provided a more eloquent explanation for
the role of glucocorticoids in stress: (a) the physiological function of stress-
induced increases in glucocorticoid levels is not to deal with the source of stress
itself, but to protect against the normal defense reactions that are activated by
stress; and (b) the glucocorticoids accomplish this function by turning off those
defense reactions, thus preventing them from overshooting and themselves
threatening homeostasis (Munck et a/., 1984).
2.1.1.2 Main pathways of the stress response
The stress response is initiated and maintained by both central and peripheral
components. Although the limbic-hypothalamic-pituitary-adrenal (LHPA) axis is
the endocrine system most closely linked to stress in mammalians, the role the
limbic system (especially the hippocampus) plays is not well understood yet
(Vazquez, 1997). Of note is the fact that hippocampal GR expression is
influenced by early environmental events in rats, which in turn may affect HPA
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axis function (Mohammed & Henriksson, 1993). Within the hypothalamus, the
paraventricular nucleus (PVN) represent the final common integration of the
stress response in the brain and it contains neurons for both corticotropin-
releasing hormone (CRH, also known as CRF, corticotropin-releasing factor) and
arginine-vasopressin (AVP). Thus, for our purpose, the hypothalamus represents
the top controlling structure of the HPA axis. The brain stem contains the locus
ceruleus (LC)-norepinephrine system (LC/NE system), which is a collective term
for the locus ceruleus and other noradrenergic cell groups of the medulla and
pons (Tsigos & Chrousos, 2002). Together, the PVN (hypothalamus) and LC
(brain stem) constitute the central control systems of the stress response. The
peripheral component of the stress response is mediated by the HPA axis and
the efferent sympathetic/adrenomedullary system (Tsigos & Chrousos, 2002).
The HPA axis mediates the release of cortisol or corticosterone whereas the
LC/NE system mediates the release of NE, E and IL-6 (Tsigos & Chrousos,
2002). A simplified schematic representation of the central and peripheral
components of the stress response is shown in Fig. 2.1.
2.1.2 The typical vertebrate endocrine stress response
When faced with a stressor, the vertebrate organism responds by initiating an
endocrine stress response that primarily consists of two waves of hormonal
secretion (Sapolsky et al., 2000). The first wave occurs within seconds after
exposure to the stressor and involves enhanced secretion of catecholamines (NE
and E) from the sympathetic nervous system as well as hypothalamic release of
CRH into the hypothalamic-pituitary portal circulation, which is followed by
enhanced secretion of ACTH (Sapolsky et al., 2000). The hormones of the first
wave exert most of their effects via rapid second messenger cascades in target
tissues within seconds and up to a few minutes (Sapolsky et al., 2000).
About four times more E is secreted than NE in humans and these hormones
exert similar functions to those of sympathetic nerves, which include:
Stellenbosch University http://scholar.sun.ac.za
PERIPHERAL
,,,,,
17
--------·CRH/AVP [hypothalamus] .... LC/NE-system [brain stem]
...
--.. ACTH [pituitary]
.A,,
CortisoltCorticosterone'-----------.
[adrenals] \~
NEtE [adrenals]
!
IL-6
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i. increased hepatic glycogenolysis and muscle glycolysis;
Figure 2.1 The two main pathways of the stress response. In mammals, the
stress response is mediated by the HPA axis and the LC/NE system. The key
peripheral effectors of these two systems are cortisol (humans) or corticosterone
(rats and mice) and IL-6, respectively (adapted from Tsigos & Chrousos, 2002).
Abbreviations: ACTH, adrenocorticotropin-releasing hormone; AVP, arginine-
vasopressin neurons; CRH, corticotrophin-releasing hormone neurons; IL-6,
interleukin-6; LC, locus ceruleus; NE, norepinephrine. Solid lines indicate
stimulatory effects; dashed lines indicate inhibitory effects.
ii. increased catabolism (breakdown) of adipose tissue thus supplying
glycerol for gluconeogenesis and fatty acids for oxidation;
iii. decreased fatigue of skeletal muscle;
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iv. increased cardiac output secondary to increased cardiac contractility and
heart rate;
v. vasoconstriction in viscera and vasodilation in skeletal muscle, thus
improving muscle function and usefulness;
vi. increased ventilation and
vii. increased coagulability of blood (Vander, 2001).
In contrast, the second wave is slower than the first and involves the steroid
hormones. During this time, GC secretion is stimulated and gonadal steroid
secretion declines (Sapolsky et a/., 2000). The bulk of steroid actions are
genomic, therefore very few GC actions are exerted until about an hour after the
onset of the stressor (Sapolsky et al., 2000). GCs cause numerous metabolic
effects such as increased blood glucose levels, stimulation of gluconeogenesis in
the liver and the mobilisation of both amino and fatty acids from muscle and
adipose tissue, respectively (Reichardt & Schutz, 1998).
2.2 Glucocorticoidphysiology
Upon ACTH stimulation, GCs are synthesized in the adrenals (will be discussed
in section 2.2.1) and secreted into the blood. GCs are then transported (will be
discussed in section 2.2.2) to target organs. The molecular mechanisms of GC
action will be discussed in section 2.2.3. Prolonged chronic stress with attendant
elevated GC levels may result in GC resistance and this section will be
concluded with a discussion of this phenomenon (section 2.2.4). Two GC-
inducible genes affecting metabolism of amino acids in response to stress will be
highlighted namely TAT (section 2.3.1) and GS (section 2.3.2). For a better
understanding of the role of GCs, the following sections will take a closer look at
basic GC physiology.
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2.2.1 Glucocorticoid synthesis
As mentioned earlier (section 2.1.1.2), the PVN, situated in the hypothalamus, is
the primary CNS nucleus involved in the regulation of the pituitary-adrenal axis
by being the principle CNS source of CRF - the major regulator of pituitary ACTH
secretion (Rivier and Plotsky, 1986).
The median eminence (ME) is the base of the hypothalamus and contains
capillaries that combine to form the hypothalamic-pituitary portal vessels
(HPPVs) that pass down the pituitary stalk into the pituitary gland (Vander, 2001).
These vessels represent an unusual blood-vessel connection between the
hypothalamus and pituitary, and thereby offer a local route for blood flow directly
from the hypothalamus to the anterior pituitary. The CRF hypophysiotropic
neurons are responsible for releasing CRF into the HPPVs. Hypophysial
(pituitary) portal vessels vascularize the anterior pituitary and transport CRF to
interact with a specific G protein-coupled receptor (CRF-R1), resulting in
stimulation of the synthesis of pro-opiomelanocortin (POMC), an ACTH precursor
peptide, as well as stimulation of secretion of ACTH and other POMC-derived
peptides (Turnbull and Rivier, 1997;Vale ef aI., 1981).
The adrenal glands are situated on top of each kidney, consisting of two layers of
cells - an adrenal medulla and an adrenal cortex, each of which function as
endocrine glands (Vander, 2001). The three distinct layers of the cortex are: (a)
zona glomerulosa - the outer cells of the cortex which predominantly produce
aldosterone from corticosterone since it lacks the enzymes necessary to form
cortisol and androgens; (b) zona fasciculata - the middle cortex layer that
produces no aldosterone but mainly cortisol and androgens; and (c) zona
glomerulosa - the inner cortex layer that also produces no aldosterone but
mainly cortisol and androgens (Vander, 2001). All of the adrenal steroid
hormones are produced in the adrenal cortex from the steroid-precursor
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cholesterol, most of which is provided by the plasma (Vander, 2001). A simplified
illustration of the steroid biosynthesis cascade is shown in Fig. 2.2. The five
adrenal cortex hormones of high physiological significance are aldosterone (the
most important mineralocorticoid), cortisol, (the most important GC in humans),
corticosterone (the most important GC in rats and mice), dehydro-
epiandrosterone (DHEA, an androgen) and androstenedione (also an androgen).
Since our interest is mainly in the GCs, cortisol and corticosterone, the other
hormones will not be discussed. ACTH potently stimulates the synthesis and
subsequent release of GCs from the zona fasciculata (Keller-Wood and Dallman,
1984; Young et aI., 1986).
The inner adrenal medulla secretes catecholamines (which form part of the first
wave of hormonal responses to stress - see figure 2.1 and section 2.1.2)
(Vander, 2001). Actually, the adrenal medulla is a modified sympathetic ganglion
with cell bodies devoid ofaxons.
Cholesterol
Progesterone 17-HPG__. Androstenedione1::::::j. Testosterone
~ 1 1
11-Deoxycorticosterone11-Deoxycortisol Oestradiol
~ 1
Aldosterone Corticosterone Cortisol
Figure 2.2 A simplified schemeshowing adrenal steroid biosynthesis.
Cholesterol is the common precursor for all the different steroids. Cortisol is the
major GC in humans, with corticosterone being its equivalent in lower species
such as rats and mice. Abbreviation: 17-HPG, 17-hydroxyprogesterone. Adapted
from Harvey, 1996.
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Instead, the cell bodies release their secretions into the blood, thereby fulfilling a
criterion for an endocrine gland (Vander, 2001). It is this direct neural activation
for release that causes one of the major differences between catecholamine and
GC response time.
2.2.2 Glucocorticoid transport in plasma
Steroid hormones (such as GCs) are lipid-soluble and, once synthesized, easily
diffuse into the blood where they mainly bind to certain plasma proteins (Vander,
2001). For example, GCs in the blood bind mainly to corticosteroid binding
globulin (CBG), which is the major transport protein for GCs in the blood of most
vertebrate species (Seal and Dou, 1965). In fact, >90% of the cortisol (human)
and corticosterone (rat) in plasma is bound by CBG, leaving a small fraction
evenly distributed between albumin and a pool of non-protein bound or "free"
steroid that is generally assumed to be biologically active (Siiteri et al., 1982;
Brien, 1981). CBG, therefore, plays a major role in cortisol metabolism by
regulating the hormone's bioavailability and metabolic clearance (Bright, 1995;
Ousova et al., 2004).
CBG is a well-conserved a-glycoprotein in vertebrates. It is synthesized in the
liver and secreted into the blood where it binds cortisol and progesterone with a
high affinity (KA - 10 nM-1) (Ousova et al., 2004). Analysis of its molecular
structure reveals that CBG belongs to the serine protease inhibitors and
substrates (SERPINS) superfamily and therefore does not share any sequence
homology with other steroid-binding proteins (Carrell and Travis, 1985;
Hammond et al., 1987; Hammond et al., 1990). Pemberton et al. showed that
CBG is a substrate of the serine-protease elastase, which cleaves CBG near its
steroid binding site resulting in the local release of cortisol at sites of
inflammation (Pemberton et al., 1988).
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Membrane receptors for CBG have also been described (Strel'chyonok and
Avakumov, 1991). These membrane receptors capture the CBG-cortisol complex
before transporting it into the cell where it subsequently dissociates
(Strel'chyonok and Avakumov, 1991). In contrast to previous perceptions, this
finding suggests that it is not only the free steroid that shows biological activity. In
vitro studies showed that after the binding of the CBG-cortisol complex to its
receptors, cAMP increased in the cell - suggesting that CBG itself may have
intrinsic biological properties (see review of Breuner and Orchinik, 2002). More
than 68% of CBG in rats remain in the cortisol-free state under physiological
conditions, supporting the hypothesis that CBG may also act as a hormone
(Gayrard et al., 1996). This, however, deserves no further elaboration since it
does not fall under the scope of interest of this thesis.
2.2.3 Molecular mechanisms of glucocorticoid action
Free or biologically active GCs diffuse into target cells where they exert a
plethora of molecular actions. Most effects of GCs, if not all, are mediated via the
Type 2 glucocorticoid receptor, the GR, a 777 amino acid protein cloned in
humans in 1985 (Hollenberg et al., 1985). The GR is a member of the
superfamily of ligand regulated nuclear receptors, which all contain modular
structures whose principal functions (ligand binding, DNA binding and activation)
are localised to specific domains (Fig. 2.3) (Giguere et al., 1986; Hollenberg and
Evans, 1988; Dahlman-Wright et al., 1995; Beato M et al., 1996).
In humans, GRs exist in two isoforms, GRu and GRp, as a result of alternative
mRNA splicing (Bamberger et al., 1995). In mice, however, no GRp has been
detected and, therefore, the effects of GCs are mediated solely through binding
to GRu (Otto et al. 1997). GRp mRNAwas found in rats, specifically in
gastrocnemius muscles (Korn et al., 1998)..
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Figure 2.3 A linear representation of the structural organization of the rat
glucocorticoid receptor (GR). Specific domains contain sites responsible for
the principle functions, viz. activation, ligand-binding and DNA-binding.
Abbreviations: AF-1 and AF-2, binding sites for activation factors 1 and 2; DBD,
DNA-binding domain; LBO, ligand-binding domain; H2N,amino terminal; eOOH,
carboxy terminal.
Although the physiological significance of GRp-expression is still unknown
(Pujols et el., 2002), it is defective in steroid binding and therefore acts as a
dominant negative inhibitor of GRu function (Bamberger et al., 1995; Oakleyet
al., 1999). However, controversy exists regarding the level of expression of GRp,
which may be due to methodological differences. Researchers who found that
GRp has low abundance in human cells and tissues suggest it is unlikely to have
any effect on GRu function (Pujols et aI., 2002).
When no ligand is present, GR is predominantly maintained in the cytoplasm of
the target cell, bound in an inactive multi-protein complex consisting of two heat-
shock protein (hsp)-90 molecules and a number of other molecules which
include, amongst others, immunophilins p59 and calreticulin (Fig 2.4) (Beato et
aI., 1996). Ligand presence and subsequent binding to the ligand-binding domain
(LBO) of the GR lead to a conformational change in the receptor, which causes
dissociation of the multi-protein complex (Beato, 1989).
Nuclear translocation (movement from the cytoplasm into the nucleus) of the GR
occurs by virtue of the nuclear localization sequence within the DNA binding
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domain (DBD), which is exposed upon ligand-induced conformational change
(Beato, 1989). In the nucleus, GR binds to DNA sequences in the promoters of
GC-responsive genes referred to as glucocorticoid response elements (GREs),
to activate or repress transcription of these responsive genes. These activating
or repressive mechanisms are known as transactivation and transrepression,
respectively.
--1 GRi:
.(!)'!)
~r-. ------T""c:;:------
Figure 2.4 The glucocorticoid receptor signal transduction cascade.
Glucocorticoid hormones enter the cell, bind to glucocorticoid receptor (GR). The
bound ligand-receptor complex translocates to the nucleus and binds to
glucocorticoid response elements in the nucleus, causing either transactivation or
transrepression. Abbreviations: CYP, cyclophilins; GRE, glucocorticoid response
element; HSP, heat shock protein; OP?, other proteins (some of which were
identified, e.g. immunophilin p59 and calreticulin) (adapted from Webster and
Cidlowski, 1999).
GR cooperatively binds classical GRE sites (Fig 2.5A) as a homodimer, i.e. two
identical activated GR molecules that have dimerized, to transactivate genes
(Newton, 2000). As an example, after ligand binding, a GR homodimer activates
transcription of the tyrosine aminotransferase (TAT) gene (section 2.3.1) - by
binding to a DNA sequence upstream of the TAT-gene promoter (Jantzen et ai.,
1987). Also, it has been shown more recently that GCs inhibit transcriptional
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repression by binding to two GREs in the GS gene promoter (Chandrasekhar et
al., 1999) (see section 2.3.2 for more details). Other modes of transactivation that
do not require dimerisation of the GR have been proposed such as the
composite GRE (Fig 2.5B) and the tethering GRE (Fig 2.5C). An example of
composite GR binding is found in the ability of GR to act synergistically either
with activator protein-1 (AP-1), a transcription factor, or its components, c-Fos
and c-Jun (Pearce and Yamamoto, 1993). Stat5 is a transcription factor that
synergistically binds with GR, without the requirement of GR-DNA-binding, which
is an example of tethered transactivation (Stocklin et al., 1997).
In contrast, GRs can also cause transrepression of genes via direct binding to a
negative GRE (nGRE) site (Figs. 2.5D-E, G) (Beato, 1989). The exact
mechanisms for the different modes of repression have not been characterized
yet, but speculations are that they may involve either protein-protein interactions
with other factors on the promoter or direct inhibition due to steric hindrance as a
result of the close proximity to the TATA box and transcription start site. Also,
binding of GR to nGRE may block binding of positive factors and thereby cause
transcriptional repression (Fig. 2.5G) (Newton, 2000). Examples of such cases,
in which transrepression is caused via DNA-binding of homodimeric GRs to
nGREs, are GR- inhibition of the POMC-gene (Figs 2.50) and the glycoprotein
hormone a-subunit gene (Fig 2.5G). Furthermore, Newton summarizes other
mechanisms of transrepression caused by GR, which involve indirect DNA-
binding (Newton, 2000). It has also been shown that monomers of GRs can
repress transcription of genes using a tethering mechanism (Fig. 2.5F), such as
the interaction between GR and the AP-1 and NF-KB transcription factors (Yang
Yen et al., 1990). The tethering mechanisms have been proposed to account for
the GC-dependent repression of genes that do not have nGRE sites in their
promoters, e.g. the inflammatory genes (Newton, 2000).
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Inflammatory protein genes, such as IL-B, IL-6 and IL-1, are the genes activated
by the transcription factors NF-KB and AP-1 (nuclear factor-KB and activator
protein-1). The ubiquitous NF-KBprotein is a heterodimer, typically consisting of
the p50 and p65 monomeric proteins (amongst others); the AP-1 protein is
composed of either homo- or heterodimers between members of the Jun (e.g. c-
Jun, Jun-B), Fos (e.g. c-Fos, Fos-B), activating transcription factor (e.g. ATF-2,
B-ATF) or Maf (e.g. c-Maf, Maf-B) families (De Bosscher et al., 2003).
GRs negatively regulate transcription by direct or indirect interference with the
transcriptional activity of the NF-KB and AP-1 transcription factors. Indirect
interference occurs because NF-KB is sequestered in the cytoplasm with IKBa,
an inhibitor, whose degradation is induced by inflammatory stimuli (Sakiatvala,
2002; Scheinman et al., 1995; Auphan et al., 1995). GR-binding to the DNA
causes increased synthesis of IKBa, which binds activated NF-KB, thus limiting
its effects (O'Connor et al., 2000; Auphan et al., 1995).
Having discussed the mechanisms of GC action, including alluding to the
mechanisms for upregulation of TAT and GS, it will be most appropriate to
discuss these GC-inducible enzymes in more detail in the following section.
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Figure 2.5 Models describing the molecular action of activated GR. (A) Homodimers
of GR bind cooperatively to classical GRE sites to activate transcription. (B) Interaction
of GR with a second transcription factor can activate transcription from composite
binding sites in a manner that involves DNA binding of both factors. (C) Interaction of GR
with a second transcription factor may result in activation of transcription in a manner
that does not require DNA binding of GR. (D) Homodimers of GR repress transcription
from a simple nGRE. (E) Interaction of GR with a second transcription factor can repress
transcription from composite binding sites in a manner that involves DNA binding of both
factors (F) Interaction of GR with a second transcription factor may result in repression
of transcription in a manner that does not require DNA binding by GR. (G) At a
competitive nGRE, binding of GR to the GRE site prevents binding of factors that are
required for transcriptional activation and therefore causes transcriptional repression
(Newton, 2000).
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2.2.4 Glucocorticoid-responsivemetabolic enzymes
As part of the "adaptive redirection of energy" that occurs with physical
adaptation during stress, the body increases gluconeogenesis and lipolysis
(Chrousos & Gold, 1992). Historically, GCs derive their name from their
involvement in increasing blood glucose levels. Current understanding of this
scenario includes a view that GCs mediate the control of gene expression of
genes involved in gluconeogenesis, amongst other processes. Of relevance to
this thesis are the genes that encode for the metabolic enzymes, GS and TAT,
which both contain GREs, which are binding sites for activated glucocorticoid
receptors. As will be explained in the next two sections (2.2.4.1 and 2.2.4.2),
these enzymes are involved in the metabolism of amino acids, which will
ultimately serve as precursors for gluconeogenesis in the liver. Due to the fact
that the activities of both these enzymes are under glucocorticoid control, their
responsiveness during chronic stress represents our focus on the metabolic
changes that occur during psychological stress.
2.2.4.1 Tyrosine aminotransferase (TAT)
Tyrosine aminotransferase (L-tyrosine: 2-oxo-glutarate aminotransferase, EC
2.6.1.5, TAT) converts tyrosine to p-hydroxyphenylpyruvate in a transamination
reaction, and thereby catalyzes the first step in the catabolism of tyrosine
(CannelIakis and Cohen, 1956). TAT is found in many organs throughout the
body, including the liver, thyroid, heart, kidney, muscle, cerebellum, cerebrum,
skin and adipose tissue (Prieur et ai., 2001). TAT activity was shown to increase
several fold in rat liver after administration of GCs and since then the liver has
become the main organ in which TAT was studied (Lin & Knox, 1958).
Corticosteroid concentrations, and subsequently TAT activity, increase after
exposure to stress (AI-Mohaisen et ai., 2000). Regulation of the TAT gene, Tat,
involves two remote glucocorticoid responsive units (GRUs), referred to as HSIII
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and HSV, which are located 2.5 and 5.4 kb upstream from the transcription start
site, respectively (Grange ef aI., 1989). Hormone-response units are clusters of
transcription factor-binding sites, comprising a hormone-responsive element and
a number of cis-elements (accessory factors). Such a hormone-response unit
allows the regulation of transcription of the gene in space and time by integrating
multiple signal pathways (Schëneveld ef al., 2004; Mitchell ef al., 1994). TAT
GRUs consist of numerous contiguous and overlapping binding sites for the GR
(viz. the GRE) and other transcription factors, including members of the C/EBP
(CCAAT/enhancer-binding protein), HNF-3 (Hepatic Nuclear Factor 3) and Ets
families of transcription factors (Jantzen ef al., 1987; Grange ef al., 1991;
Espinás ef al., 1994; Roux ef al., 1995). Grange ef al. showed that cell type-
specific GC response in rat hepatoma cells is associated with binding sites for
the cell type-specific nuclear proteins in TAT gene GRUs (Grange ef al., 1991).
Full glucocorticoid induction of the rat TAT gene is achieved through cooperative
interaction of the remote GRUs (Grange ef aI., 1989). HSIII contains three GR
binding sites, known as GRE 1, 2 and 3, of which GRE 2 and 3 are located within
regions necessary for HSIII activity (Jantzen ef al., 1987). HSV contains a GR
binding site essential, but not sufficient, for its activity since it lacks flanking
sequences (Grange ef al., 1991). HSV is non-active in the absence of HSIII
(Grange ef al., 1991).
Of particular relevance to this thesis is the TAT gene and the mechanism for its
transactivation by GR. It has been shown that the GR uses a dynamic multistep
mechanism to recruit accessory DNA binding proteins that assist in the activation
process of the TAT gene (Grange ef al., 2001). The three successive steps are
(i) chromatin remodeling, (ii) DNA demethylation and (iii) synthesis of accessory
factors (Grange ef al., 2001). The accessory factors are the proteins that
contribute slightly but additively to the activity of the GRU (Grange ef al., 2001). A
typical GRU will consist of one or more GREs with additional binding sites for
related transcription factors such as C/EBP (Grange ef al., 2001). A stable
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multiprotein complex is formed, which interacts with the regulatory element - then
only can efficient transcriptional induction be achieved (Grange et ai., 2001).
Apart from GCs, insulin and glucagon also control TAT activity (Holten & Kenney,
1967; Ernest & Feigelson, 1979). Earlier research has shown that insulin induces
TAT mRNA and directly influences TAT activity (Reel et ai., 1970; Spencer et ai.,
1978), whereas, in the presence of glucocorticoids, insulin acts at a post-
transcriptional level only increasing TAT activity (Crettaz et ai., 1988). However,
more recent research has shown that insulin has a negative effect on genes that
contain a PEPCK-like motif (a type of motif that defines an insulin response
sequence, IRS), which includes the gene that expresses TAT (O'Brien et ai.,
2001; O'Brien & Granner, 1996). It has also been shown that insulin inhibits
gluconeogenesis (Ganss et ai., 1994). In contrast, glucagon binds to cell surface
receptors and activates a second messenger system (cAMP), which leads to
phoshorylation and activation of a variety of transcription factors that up-regulate
TAT expression and hence activity (Schmid et ai., 1987).
Glucocorticoid-induction of TAT has been investigated in various in vitro models,
e.g. TAT induction by dexamethasone phosphate in cell culture (Granner et ai.,
1968). It was shown that TAT accumulation on induction is due to an increase in
its rate of synthesis (Granner et ai., 1968). Also, studies on the hepatic tissue
culture (HTC) system have suggested that dexamethasone stimulates both the
accumulation of TAT mRNA and its translation into protein (peterkofsky &
Tomkins, 1967; Tomkins et ai., 1966). During 1970, a report by Granner et al.
concluded that steroid presence is constantly required for maintenance of the
induced rate of synthesis (Granner et ai., 1970). More recently, the in vivo effects
of chronic methylprednisolone (MPL)-infusion in adrenolectomised rats were
investigated (Ramakrishnan et ai., 2002; DuBois et ai., 1995). An early rise in
TAT activity was found after 6 hours of MPL treatment, but this was followed by a
dramatic decrease which stabilized at values close to control values after 24
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hours of MPL treatment (Ramakrishnan et ai., 2002). However, the exact
mechanisms of these effects remain unclear.
The effects of cytokines on TAT activity have not received much attention over
the past fifteen years. In an earlier report, the interaction between cytokines and
TAT activity were investigated in rat hepatoma FAO cells and it was found that
the cells in the IL-6-containing media increased their TAT activities (Guzdek et
ai., 1995). More recently, it was shown an IL-6 chimera (IL-6/soluble IL-6
receptor) was able to dose-dependently reduce the expression of tyrosine
aminotransferase in fetal hepatocytes (Zvibel et ai., 2004). Based on these
conflicting reports, it became of interest to us to determine what effects cytokine
action would have on TAT expression in vivo.
Furthermore, a diurnal variation in TAT enzyme activity has been reported,
which, according to the authors, appeared to be independent of adrenal activity,
an assessment which appears to be contradictory to their results, as illustrated in
Fig 2.6 (Wurtman and Axelrod, 1967). However, it has since been shown that
GCs, as explained before, regulate TAT enzyme expression. Yi-Li et al. showed
that there is a good correlation between the level of GR and induction of TAT in
rat liver, and that down-regulation of GR led to a decrease in TAT induction (Yi-Li
et ai., 1989). At the level of activity-expression relationship, DuBois et al.
showed that the profile of TAT activity exhibits similarities to the profile of TAT
mRNA expression (DuBois et ai., 1995), i.e. a rise in TAT activity is concomitant
with an increase in TAT mRNA levels.
2.2.4.2 Glutamine synthetase (GS)
Glutamine synthetase (GS; L-glutamate:ammonia ligase (ADP-forming); EC
6.3.1.2.) is a "housekeeping" enzyme that is expressed at a particularly high level
in neural tissues (Grossman et ai., 1994; Patejunas and Young, 1987), skeletal
muscle and lungs (Souba, 1987; Souba & Austgen, 1990). Muscle and lungs
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synthesize and release glutamine (Gin) into the blood (Souba, 1987; Souba &
Austgen, 1990).
HEPATIC TYROSINE TRANSAMINASE
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Figure 2.6 Daily rhythms in hepatic tyrosine aminotrasferase (TAT) and
adrenal corticosterone content. The graph clearly demonstrates that increased
TAT activity follows the rise in adrenal corticosterone levels. Rats were kept
under controlled illumination (lights on: 8 a.m. to 8 p.m.) for 1 wk prior to assay.
Vertical lines in both figures represent standard errors of the mean (Taken from
Wurtman and Axelrod, 1987).
Gin is the most abundant free amino acid in the blood and tissues of humans and
rats (Bergstrom et el., 1974; Ardawi & Jamal, 1990). The many physiological
roles of this amino acid include substrate for renal ammoniagenesis (Welbourne
et el., 1986), precursor for nucleotide biosynthesis (Austgen et el., 1992),
regulator of muscle protein turn-over (Rennie et aI., 1989) and vehicle for
nitrogen-transfer between tissues (Souba, 1987). Glutaminase is the other key
enzyme involved in Gin metabolism - it catalyses the hydrolysis of Gin to Glu
(Souba et aI., 1985). Enterocytes, lymphocytes and endothelial cells consume
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Gin in large amounts and have more glutaminase than GS (Souba et ai., 1990;
Newsholme & Parry-Billings, 1990; Souba & Austgen, 1990).
In skeletal muscle, the conversion of muscle protein and amino acids into Gin
provides an important source of Gin during stress, when there is often an
increased demand or limited supply of it (Labowet ai., 1999). Glu is converted to
Gin (GS-catalyzed reaction), which the muscle releases into the blood from
where it is taken up by the kidney and cells of the immune system (Salway,
1994). Increased transcription in response to hormone action represents one of
two major ways by which GS expression in mammalian systems is regulated
(Labowet ai., 2001). The other manner of regulation of GS expression occurs
through regulation of protein stability in response to Gin concentration (Labowet
ai., 2001). As part of the acute stress response, GCs are rapidly released, which
in turn up-regulate muscle GS gene expression in vitro and in vivo (Max et ai.,
1988; Max, 1990). Also, muscle GS mRNA levels have been shown to rise in
response to endotoxin challenge in a manner that is predominantly adrenal gland
dependent (Lukaszewicz et ai., 1997). Muscle GS mRNA levels can be rapidly
increased due to GCs during acute stress (Labowet aI., 1999). Chronic stress
can cause Gin to impact directly on GS gene expression or potentiate the effects
of another mediator; however, significant increases in GS gene expression can
occur without changes in tissue Gin levels or circulating GCs (Labowet ai.,
1999). GS expression in skeletal muscle tissue is regulated by both
transcriptional and posttranscriptional mechanisms - Gin appears to affect GS
expression (in muscle) differently during acute stress compared with chronic Gin
and/or caloric deprivation (Labowet aI., 1999).
The rat GS gene contains two regions which were identified as conferring
significant GC inducibility (Chandrasekhar et ai., 1999). One region is located far
upstream (nearly 6 kb) from the transcriptional start site of the GS gene and the
other is located in the first intron. A GRE is located in the intron region and three
separate GRE half-sites are contained in the far upstream region (Labowet ai.,
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2001). Current speculations are that GC regulation of GS expression is regulated
by transcriptional repression in the absence of hormone caused by the two
separate elements within the GS gene (Chandrasekhar et ai., 1999). In short, the
GC inducibility of GS in lung and muscle may be due to relief from transcriptional
repression, which does not operate in tissues (such as liver and kidney) with a
higher basal expression of GS (Chandrasekhar et ai., 1999). Thus, GC-induced
GS expression may explain the ability of lung and muscle to increase GS
expression in catabolic states, e.g. exercise and stress (Chandrasekhar et ai.,
1999). In addition, a more recent study has confirmed the existence of an
inhibitory GRU in the GS gene, which showed GC-dependence in muscle cells
and is located approximately 1.6 kb upstream from the transcriptional start site of
the GS gene promoter (Garcia de Veas Lovillo et ai., 2003). This suggests that
both positive and negative elements, as well as interactions between them,
regulate GS promoter activity in vitro (Garcia de Veas Lovillo et ai., 2003).
Although the only known mediator of GS gene expression appears to be GCs,
other factors (~-adrenergic agonists, cyclic AMP, epidermal growth factor, insulin
and thyroid hormones) affect GS levels in the brain (de Vellis et ai., 1986; Khelil
et ai., 1990; Q'Bannion et ai., 1994; Jackson et ai., 1995). Chao et al. showed
that IL-1~ and TNF-a have no direct effect on GS protein levels while Huang and
Q'Bannion showed that IL-1~ and TNF-a down-regulate the dexamethasone
(dex)-induction of GS (Chao et ai., 1992; Huang and Q'Bannion, 1998). No
studies thus far have focused on peripheral GS expression in response to
immobilisation stress in combination with an intervention that can probe the role
of IL-6.
In keeping with the notion that GCs must "prevent the stress-response from
overshooting" (Munck et ai., 1984), the concept of GC resistance must be
discussed.
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2.3 Glucocorticoid resistance
'Glucocorticoid resistance' is the term that describes decreased target sensitivity
to GCs (a decrease in GR expression), also associated with compensatory
hypersecretion of glucocorticoids (Chrousos et al., 1993). Thus, elevated plasma
concentrations of GCs are often used as an index of stress. Chronic stress
(including psychological stress) and the attendant chronic hypersecretion of GCs
have been linked to many different pathologies (Chrousos and Gold, 1992;
Chrousos, 1995). The elaborate mechanisms responsible for maintaining GC
homeostasis compensate for the insensitivity of tissues to glucocorticoids by
resetting the hypothalamic-pituitary-adrenal axis. Thus, CRH, ACTH and cortisol
secretion are increased. The compensatory increase in ACTH production causes
increased secretion of GC precursors with mineralocorticoid activity
(deoxycorticosterone, DOC; corticosterone, B) and increased secretion of several
adrenal androgens (Fig 2.7) (Chrousos et a/., 1993). Although the GC
concentrations in circulation is increased, they fail to exert their effects on the
target tissues. Different molecular defects alter the functional characteristics or
concentrations of the intracellular GR, which may be responsible for the
development of glucocorticoid resistance (Chrousos et ai., 1993).
Several authors have shown that a single acute stress resulted in dramatic 3- to
4-fold elevation in plasma corticosterone levels (Omrani et ai., 1980; Sapolsky et
ai., 1984; Meaney et ai., 1991; Alexandrova, 1994; AI-Mohaisen et ai., 2000).
The last of these groups found that plasma corticosterone levels remained 2- to
3-fold above basal levels during persistent repeated immobilization stress of 30
days duration (AI-Mohaisen et a/., 2000).
GR availability (the amount of cytosolic GR that is available for binding to
corticosteroid ligand) influences subsequent steroid responsiveness, which
warrants the study of changes in GR levels during repeated stress. Due to
inconsistent methodology, controversy exists in the literature regarding GR levels
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after exposure to chronic stress. Steroid unoccupied receptors have been
measured by using radioligand binding assays and the decrease in cytosolic GR
is often attributed to its translocation into the nucleus due to increasing
corticosterone levels (AI-Mohaisen ef al., 2000).
Hypothalamus
NonMI
Figure 2.7 Pathophysiological mechanism of glucocorticoid (GC)
resistance. With the normal physiological condition, the hypothalamus is
sensitive to stimuli that promote the secretion of CRH. In contrast, subsequent
GC resistance leads to hypersecretion of CRH, ACTH and cortisol, which
desensitizes the hypothalamus to further endocrine stimuli. ACTH,
adrenocorticotrophic hormone; CRH, corticotrophin releasing hormone; DOC,
deoxycorticosterone; B, corticosterone (Adapted from Chrousos ef al., 1993).
However, in their article, AI-Mohaisen ef al. also claim that their methodology
which combined an unoccupied receptor assay and a total receptor exchange
binding assay, measured true total GR for the first time. Their data suggested
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that previous studies, mostly using free receptor binding assays, underestimated
the GR levels by not measuring steroid occupied GR during chronic stress (AI-
Mohaisen et aI., 2000). They found an increase in total GR after exposure to
chronic stress, in disagreement with what most studies on the issue have shown
(reviewed in AI-Mohaisen et aI., 2000). Following their report, no study on chronic
stress has supported this viewpoint, and no other researcher has tested this
'new' approach. We thus remain skeptical with regards to the feasibility of this
new methodological approach.
AI-Mohaisen et al. found that unoccupied cytosolic GR decreased during both
acute and repeated stress in the rat liver (AI-Mohaisen et aI., 2000). As
mentioned before, they found that occupied and total cytosolic GR levels
increased in liver during 7-30 days of repeated immobilization (AI-Mohaisen et
aI., 2000). Prior to aforementioned study, a general interpretation held that
cytosolic GR levels decreased after chronic stress (Sapolsky et aI., 1984; Reul et
aI., 1990). Sapolsky et aI., in male Fisher 344 and Long-Evans rats, observed
reduced GR number (assessed by radioligand receptor binding assay) in
amygdala and hippocampus during repeated immobilization stress (Sapolsky et
aI., 1984). Alexandrova and Farka reported that 15 days of repeated stress
resulted in down-regulation of GR (assessed by radioligand receptor binding
assay) in rat liver (Alexandrova & Farka, 1992). Swimming stress caused a
dramatic increase in plasma corticosterone levels with a sharp decline in hepatic
cytosolic GR levels (Omrani et aI., 1980). Two other groups found down-
regulated GR expression in rat hippocampus during chronic stress, using in situ
hybridisation and immunoautoradiography, respectively (Gomez et al., 1996;
Herman & Spencer, 1998). In contrast, Lowy found no changes in GR density of
various tissues of rats after repeated immobilization stress for 5 days (Lowy,
1991). The conflicting reports may possibly be due to the different strains of rats
used in these mentioned studies as well as methodological differences.
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Immunological approaches (e.g. immunoblotting, immunoreactivity, enzyme-
linked immunoabsorbent assays) have also been used to measure GR protein
levels. For instance, and in contrast to above-mentioned studies, significantly
increased GR immunoreactivity in hippocampal subregions of chronically
stressed rats was measured (Kitayama et ai., 1989; Biagini et ai., 1993). In
addition, Curtis and Rarey, by using an enzyme-linked immunoabsorbent assay,
reported elevation of GR levels in spiral ligament tissues of rats after 2 days of
immobilization stress (Curtis and Rarey, 1995). Table 2.1 summarizes some of
the different GR responses as discussed above.
AI-Mohaisen et al. proposed that their observed up-regulation of GR may be an
adaptive and protective response for survival during prolonged and persistent
stress (AI-Mohaisen et al. 2000). The majority of these studies have investigated
GR expression in the brain, which does not help to understand the metabolic
effects that stressors might have on the organism. In this respect we thought it
would be most relevant to investigate peripheral GC action (plasma
corticosterone levels; GR binding activity in liver and muscle) in response to
psychological stress.
Following this discussion on GCs, the next section will shift its focus to cytokine
physiology, which will ultimately lead to discussion of the cross-talk that exists
between the cytokine and endocrine systems.
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Table 2.1 Summary of in vivo GR responses of rats to different stress paradigms
Authors, Date Stressor(s) and Dose Duration Tissue Type of GR assay GR Result
Omrani etai., 1980 swimming 2min liver total GR exchange down-regulation
binding assay
Golikov et al., 1981 IMO 48 h liver radioligand receptor down-regulation
binding assay
Sapolsky et al., 1984 IMO 4days brain radioligand receptor down-regulation
binding assay
Kitayama et ai., 1989 IMO 14 days brain immunocytochemistry up-regulation
Gagnon et al., 1987 IMO not cardiac radioligand receptor down-regulation
available muscle binding assay
Lowy, 1991 corticosterone 10 mg/kg; 5days brain radioligand receptor Cort: down-regulation;
IMO 2h/day binding assay IMO: no change
A1exandrova & Farkas, swimming or heat or cold Acute; or liver radioligand receptor down-regulation (after swimming and
1992 or IMO or 3xperday binding assay after histamine inj)
10 mg/kg histamine; for 18
500 mU/kg vasopressin days
Biagini eta/., 1993 open field; 3weeks brain immunocytochemistry up-regulation
noise and light
Cutis & Rarey, 1995 IMOe h/day between 2 brain ELISA up-regulation
& 21 days
Gomez et a/., 1996 IMO not brain in situ hybridisation down-regulation
available
AI-Mohaisen ef al., IMO 2 h/day 7,150r30 liver radioligand binding down-regulation of free cytosolic GR;
2000
..
days receptor assay; up-regulation of bound cytosollc GR
exchange assay; & total cytosolic GR
westem blotting
Hu ef al., 2000 IMO 2 h/day OR DHEA: 5 60 days liver, thymus, westem blotting IMO: up-regulation
mg/0.1 ml DMSO daily i.p. spleen DHEA: down-regulation
Gursoy et al., 2001 CR 30% of ad libitum diet 8weeks liver, thymus, westem blotting CR: down-regulation;
with or without IMO 2 hid heart, testis CR + IMO: down-regulation
Sun et ai., 2002 sepsis by cecal ligation acute skeletal radioligand receptor up-regulation
and puncture muscle binding assay..IMO, Immobillsation stress; CR, calone restriction; GR, glucocorticoid receptor, i.p., intra-peritoneal: s.c., sub-cutaneous, cort, corticosterone,
ELISA, enzyme-linked immunosorbent assay
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2.4 Cytokine physiology
2.4.1 Definition
Cytokines are generally defined as 'regulatory proteins, secreted by white blood
cells and a variety of other cells in the body, whose pleiotropic actions include
numerous effects on cells of the immune system and modulation of inflammatory
responses' (Thomson, 1991). Amidst many different ideas about what exactly a
cytokine is, despite the definition of Thomson as shown above, the term
'cytokine' encompasses the 'monokines' (monocyte/macrophage-derived
mediators) and 'Iymphokines' (lymphocyte-derived mediators) (Turnbull and
Rivier, 1999). Cytokines are large, soluble polypeptide mediators (with molecular
mass ranging between 8 and 60 kDa) that regulate growth, differentiation and
function of many different cell types (for a review see Turnbull and Rivier, 1999).
Table 2.2 shows the main classes of cytokines with examples of each.
The arbitrary classification of cytokines into the different families remains
controversial, but for purpose of this thesis focus is placed only on the IL-1 and
IL-6 cytokine families. The remainder of this section will briefly discuss the
properties of these cytokines and their actions, which will be followed by a proper
account regarding the cross-talk between the endocrine and cytokine systems. I
shall discuss mainly IL-1 and IL-6 since (1) they are closely linked and (2) the
experimental part of this study is mainly interested in IL-6 and its action during
the stress response.
2.4.2 Basic physiology of interleukins (IL-1 and IL-6)
The name 'interleukin' and the designation of IL-1 were coined at the 2nd
International Lymphokine Workshop in Switzerland, 1979 (Di Giovine & Duff,
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1990). IL-1 has since been perceived as a major biological mediator in every
organ system and is regarded as the 'prototypic' inflammatory cytokine (Di
Giovine & Duff, 1990; Rothwell & Luheshi, 2000).
Table 2.2 Table showing different families of cytokines (from Turnbull and
Rivier, 1999).
Family of Cytokines Members
Interleukins IL-1 to IL-18
Tumor necrosis factors TNF-a, TNF-~
Interferons IF-a, -~, -y
Chemokines IL-8/cinc/gro/NAP-1, MIP-1a, -~, RANTES
Hematopoietins (neuropoietins) IL-6, CNTF, LlF, OM, IL-11, CT-1
Colony stimulating factors G-CSF, M-CSF, GM-CSF, SCF, IL-3, IL-5
Neurotrophins NGF, BDNF, GDNF, NT-3, NT-6
Growth factors IGF-1, IGF-II, EGF, aFGF, bFGF, PDGF, TGF-
a, TGF-~, activin
..
Abbrevietions: aFGF, acidic fibroblast growth factor; BDNF, brain-derived neurotrophic factor;
bFGF, basic fibroblast growth factor; cinc, cytokine-induced neutrophil chemoattractant; CNTF,
ciliary neurotrophic factor; CT-1, cardiotropin-1; EGF, epidermal growth factor; G-CSF,
granulocyte colony stimulating factor; GDNF, glial-derived neurotrophic factor; GM-CSF,
granulocyte-macrophage colony stimulating factor; gro, growth-related oncogene; IGF, insulin-like
growth factor; IL, interleukin; IL-1 ra, IL-1 receptor antagonist; IFN, interferon; LlF, leukemia
inhibitory factor; M-CSF, macrophage colony stimulating factor; MIP, macrophage inflammatory
protein; NAP, neutrophil activating protein; NGF, nerve growth factor; NT, neurotrophin; OM,
oncostatin M; PDGF, platelet-derived growth factor; RANTES, regulated upon activation normal
and secreted; SCF, stem cell factor; TGF, transforming growth factor; TNF, tumor necrosis factor.
IL-1 is a family of three closely related proteins that are products of separate
genes (Rothwell & Luheshi, 2000). IL-1a and IL-1p are the agonists and are
believed to exert identical actions via binding to a single 80 kDa cell surface
receptor, interleukin-1 receptor (IL-1R) (Sims et aI., 1988). When activated by
binding of IL-1, the receptors initiate signaling pathways that lead to the release
of secondary substances (e.g. prostaglandins and nitric oxide) that mediate
inflammation and tissue remodeling (Dinarello, 2000). IL-1 receptor antagonist
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(IL-1 RA) is the third member of the IL-1 family and is a naturally occurring
cytokine in the IL-1-family of cytokines whose primary function is the prevention
of any biological response that may occur as a result of IL-1 binding (Dinarello,
2000). Thus, the ratio of IL-1 to IL-1RA determines the net biological response
elicited by the cytokin-receptor-complex.
IL-6 is a pleiotropic pro-inflammatory cytokine, produced by cells of the immune
system (Van Snick, 1990; Akira et al., 1990) as well as by cells in neuronal and
endocrine tissues, such as the hypothalamus (Schobitz et al., 1993; Muramani et
al., 1993), the anterior pituitary (Spangelo et al., 1990) and the adrenal cortex
(Judd & McLeod, 1992). IL-6 plays important roles in immune function (Van
Snick, 1990; Akira et al., 1990; Hirano et al., 1990), hepatic acute phase protein
synthesis (Heinrich et al., 1990; Geiger et al., 1998), HPA axis activation
(Navarra et al., 1991; Lyson & McCann, 1991; Perlstein et al., 1993) and
emotional behaviour (Butterweck et aI., 2003). Based on this range of functions,
IL-6 is thought to be a hormone (Manfredi et aI., 1998). In addition, IL-6 exerts
several actions on the CNS and is implicated in development of neural and
development disorders (HOIIet al., 1996).
IL-6 belongs to a family of cytokines that all interact with the common
transmembrane cell-surface protein, gp130 (Turnbull & Rivier, 1999). In contrast
to most other classes of receptors, the cytoplasmic domain is not necessary for
proper signal transduction (Arzt, 2001). IL-6 binds to IL-6Ra (the a subunit of the
functional receptor), which triggers the association of IL-6Ra with gp130 (Arzt,
2001). The association of the IL-6I1L-6Ra complex with gp130 leads to the
homodimerization of gp130, which is a prerequisite for signal transduction
through the IL-6R complex (Arzt, 2001). IL-6Ra is an IL-6-specific receptor and is
therefore responsible only for binding of its ligand, IL-6 (Turnbull & Rivier, 1999).
In the adrenal glands, IL-6 receptor-a (IL-6Ra) mRNA has been detected mainly
in zonas glomerulosa and fasciculata, as well as in the adrenal medulla
Stellenbosch University http://scholar.sun.ac.za
43
(Cunningham et aI., 1992; Gadient et aI., 1995; Path and Bornstein, 1997).
These data confirm the possibility of communication between IL-6 and GCs, but
do not shed light on the exact mechanism or result of such communication. In the
following section I will discuss evidence for cross-talk between cytokines and
GCs. However, since the adrenals do not stand alone in the stress response, the
discussion will, once again, begin with the elements of the HPA axis. Also, since
it is difficult to discuss cross-talk between cytokines and GCs focusing only on IL-
6, the discussion will include literature regarding IL-1, since more is known about
IL-1with relation to psychological stress.
2.5 Bi-directional interaction between endocrine and cytokine systems
Immune system activation in response to e.g. infection or other stressors leads to
a classic stress response by activation of the HPA axis and sympathetic nervous
system (SNS) (Maier, 2003). Numerous types of injury, infection, disease and/or
psychological conditions are associated with increased production of
endogenous cytokines that appear to increase concomitantly with elevations in
HPA axis activity: head trauma, cerebral ischemia (stroke), autoimmune
diseases, psychiatric and dementia disorders, AIDS and antigenic challenges
(Turnbull and Rivier, 1999). The brain controls both HPA and SNS activity,
therefore, the 'sickness pattern' can also be seen to include a centrally
coordinated response (Maier, 2003; Kluger et aI., 1996).
Glucocorticoids and catecholamines, as mentioned earlier, are the endpoints of
these systems - they function by e.g. promoting production and release of energy
by means of stimulating the conversion of glycogen to glucose as well as the
breakdown of protein into amino acids, which are used in gluconeogenesis. The
brain is important in regulating the roles of peripheral organs (the main peripheral
organs involved in energy metabolism are the liver and skeletal muscles) and
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immune cells during host defense, hence the existence of communication
between the brain and the immune system (Maier, 2003). Immune system
organs,. such as the thymus, spleen, lymph nodes, gut-associated lymphoid
tissue (GALT) and bone marrow, are innervated by terminals of the SNS (Felten
et aI., 1985) and cells of the immune system express receptors for
catecholamines (Sanders et aI., 2001) as well as for hormones of the HPA axis
and other hormones (Miller et aI., 1998).
Despite the number of examples, direct and clear evidence for the involvement of
particular cytokines in the HPA axis response to such insults has been limited to
only a few cases, viz. viral or bacterial infection, local tissue damage and
inflammation and acute physical/psychological stress. Also, the cytokine
response to a stimulus that does not result in tissue damage or infection is quick
(within minutes), suggesting a role for cytokines in homeostasis that has only
recently received attention (Turnbull and Rivier, 1999). Direct demonstration of
cytokine involvement in physiological or pathophysiological HPA axis responses
has been restricted largely to IL-1, IL-6 and TNF-a.
2.5.1 Cytokine production in response to stress
Cytokines seem to be at the interface between the cognitive perception of the
stressor and its physiological sequelae (Wilson et aI., 2002). Proof of this is
provided by studies showing that administration of cytokines produces alterations
in monoamine neurotransmitter systems that resemble those seen in states of
stress (Connor and Leonard, 1998; Merali et aI., 1997; Song et aI., 1999). For
example, systemic administration of IL-1 caused a modest increase in release of
NE (in both the nucleus accumbens and the hippocampus) and dopamine (DA, in
the hippocampus) (Merali et al., 1997). In the same study, a mild neurogenic
stressor was applied, which led to even greater increases in NE and DA release,
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as well as an increase in serotonin release (Merali et aI., 1997). Rats subjected
to immobilisation stress increased their expression of hypothalamic IL-1p, which
was followed by a progressive rise in the serum IL-6 level, thus indicating that
hypothalamic IL-1 plays a pivotal mediating role in the stress-induced peripheral
IL-6 production (Ishikawa et aI., 2001).
Studies during the last 15 years have shown that synthesis and/or secretion of
IL-1 and IL-6 are altered during acute physical or psychological stress (e.g.
LeMay et aI., 1990; Mekaouche et aI., 1994; Minami et aI., 1991; Shintani et aI.,
1995a; Shintani et aI., 1995b; Zhou et aI., 1993). The sites of synthesis and/or
secretion assessed in these studies ranged from the midbrain to the
hypothalamus, as well as peripheral sites (the latter will be discussed in more
detail in section 2.5.3). As a result, physical or psychological stress increases
circulating IL-6 concentrations (LeMay et aI., 1990; Tataki et al. 1994; Zhou et aI.,
1993). Experimental models that have resulted in elevated plasma IL-6 levels in
rats include exposure to a novel environment, conditioned aversive stimuli,
electroshock or restraint (LeMay et aI., 1990; Morrow et aI., 1993; Turnbull and
Rivier, 1995a; Zhou et aI., 1993). The time course of this response is variable,
depending in part on the type of stress. IL-6 mRNA is elevated in the midbrain
and IL-6R mRNA is diminished in the midbrain and hypothalamus 4-24 h after
restraint stress in the rat (Shizuya et aI., 1997). In mice, exposure to
immobilization stress for 30 minutes caused elevated hepatic and splenic IL-6
mRNA expression, followed by an increase in serum IL-6 concentrations
(Kitamura et aI., 1997). The increases in serum IL-6 levels after physical and/or
psychological stresses in rats are much more rapid (within 15 min) than those
observed after either local or systemic inflammations (1-3 h) and appear to be
mediated by the actions of catecholamines (De Rijk et al., 1994; Soszynski et al.,
1996; Takaki et aI., 1994;Van Gooi et al., 1990). Increases in blood levels of IL-6
do not appear to directly contribute to the HPA axis response to acute stress
because, even though IL-6 levels increase rapidly, they still lag behind plasma
ACTH responses (Turnbull and Rivier, 1995a; Zhou et aI., 1993). Table 2.3
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summarizes the effects that different stressors have on the in vivo production of
IL-6.
However, the possibility of some communication between IL-6 (or other
cytokines) and the adrenals is still a topic of research. In animal models,
stressors such as acute restraint stress, immobilisation or tail shock induces
hypothalamic IL-1p and IL-1p mRNA expression within 30 min of commencement
of stress (Minami et aI., 1991; Suzuki et a/., 1997; Shintani et aI., 1995b). Chronic
exposure to physical or psychological stress elevates plasma IL-1p
concentrations in rats and humans and hypothalamic IL-1p mRNA in mice
(Mekaouche et aI., 1994; Spivak et aI., 1997; Tagoh et aI., 1995). These models
of chronic exposure lasted from 4 days to a few years after exposure to traumatic
and other stressful events.
2.5.2 Cytokine production after dexamethasone and CRH treatment
Dexamethasone does not influence either basal or IL-1p-induced IL-6 secretion
in zona glomerulosa cells (Judd and MacLeod, 1992). These authors also
showed that ACTH administration increases release of IL-6 from zona
glomerulosa cells, but not from zonas fasciculata or reticularis cells, despite
similar ACTH-stimulated cAMP levels in each cell type - suggesting, at that
stage, that HPA axis activation may cause IL-6 secretion from the adrenal (Judd
and MacLeod, 1992). More recently, it was shown that IL-6 release from the
adrenals during inflammation is CRH-dependent (Venihaki et aI., 2001). Also,
peripheral CRH induces NF-KB DNA-binding in mouse thymocytes, providing
proof that CRH fulfills a pro-inflammatory function (Zhao & Karalis, 2002),
supporting the idea that not only do inflammatory agents influence HPA axis
function (as discussed in the ensuing section), but that the HPA axis may in turn
also regulate inflammatory actions during the stress response (thus fulfilling a
proinflammatory function). It has been shown that GCs inhibit the production of
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Table 2.3 Summary of the effects of different stressors on the in vivo production of IL-6 in rodents
Author, Date Experimental Stressor(s) Duration Time of Parameter Assay details IL-6 results
Model and Dose sacrifice after measured,
stress tissue
LeMay et aI.,
._.._.__ ..._._-- -----
plasma IL-6 ELISA
"~.-.-..,,... .._--
rats psychological stress increase
1990 (open field)
Zhou eta/., rats EF,.PR orCAS EF: 1 to 16 EF: after 1, 3, plasma IL-6; IL-6 increase (in
1993 footshocks; 8 or 16 IL-6 activity; production: plasma IL-6);
PR: 60 min; footshocks; IL-6 production splenic cell decrease lin
CAS: 64 PR and CAS: culture; IL-6 production
min sacrificed IL-6 activity from spleen
exposure to immediately IL-6 bioassay cells and
16 shocks after last PBMCs)
stressor
Shizuya et a/_. rats PR (-restraint 4h immediately to IL-6 mRNA-and RT-PCR Midbrain:
1997 stress) 24h IL-6R mRNA in increase (IL-6
midbrain and mRNA);
hypopthalamus decrease (IL-
6R mRNA)
Hypothalamus:
no change (in
IL-6 mRNA);
decrease (IL-6
mRNA)
Kitamura et aI.• mice IMO 1 h immediately serum IL-6; serum IL-6: increase (in
1997 liver IL-6 mRNA; ELISA; serum IL-6);
spleen IL-6 liver and increase (in
mRNA spleen IL-6 liver and
mRNA: spleen IL-6
immunohisto- mRNA)
chemistry
Ishikawa et al., rats IMO 1 h serum IL-6 ELISA increase
2001 _._ ...._.~_.;-: ...._ ..._, ...... . .
IMO, lmmoblnsatton stress; RT-PCR , reverse transcnptase-polymerase chain reaction, EF, electnc footshock, PR, physical restraint, CAS, conditioned aversive
stimulus; PBMC, peripheral blood mononuclear cell; IL-6, interleukin-6
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IL-6 from monocytes, endothelial cells and fibroblasts (Waage et al., 1990). Also,
dexamethasone was shown to increase IL-6 receptor mRNA in a rat hepatoma
cell line (Geisterfer et al., 1995).
It has now been established that the HPA axis indeed exerts effects on cytokine
release, which paves the way for discussing effects that cytokines have on the
HPA axis in the following section.
2.5.3 Cytokine influence on the HPA axis
2.5.3.1 Hypothalamus and pituitary
Intrahypothalamic administration of IL-1ra produces a significant reduction in the
plasma ACTH response to immobilization in rats, suggesting that IL-1 has a role
in regulation of the HPA axis response to stress that is unrelated to the more
commonly accepted role in infection or inflammation (Shintani et al., 1995a;
Shintani et al., 1995b). In support of this, others have shown increases in the
hypothalamus of (1) IL-1~ mRNA expression (Minami et al., 1991; Suzuki et al.,
1997), (2) IL-1ra mRNA (Suzuki et al., 1997), and (3) IL-1 bioactivity (Shintani et
al., 1995b) after 30 min of immobilization stress in the rat. Also (as mentioned
before), increased IL-6 mRNA was measured in the midbrain 4-24 h after
restraint stress (Shizuya et al., 1997). Other studies suggest that IL-1 may also
mediate some behavioural effects of non-inflammatory/infectious stresses, for
example, enhancement of fear conditioning (Maier and Watkins, 1995). Our
interests, however, focus on the interaction that exists between cytokines and
various other components of the HPA axis, e.g. GCs and GRs.
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2.5.3.2 Cyfokines and adrenal glucocorticoid secretion
Recalling from section 2.2.1, GCs are secreted from the outer layered adrenal
cortex cells whereas catecholamines and other neurotransmitters are secreted
from the inner layered adrenal medulla. Also, large constitutive pools of Il-1a
and -13 have been identified in the adrenal glands: Il-1a, Il-1j3 and Il-1 ra
proteins have been detected in adrenal chromaffin cells (cells situated in the
adrenal medulla and named due to positive staining with chromium salts;
traditionally known to secrete the rush of adrenaline that is secreted after
activation of the 'fight or flight' response) (Schultzberg et aI., 1989; Schultzberg et
aI., 1995). Interleukin-1a, Il-1j3, Il-1j3 converting enzyme (ICE) and Il-1ra mRNA
have been shown to be present in the adrenal cortex and are markedly elevated
in both the adrenal medulla and cortex 90 min after lPS administration
(Schuitzberg et aI., 1989; Schuitzberg et aI., 1995; Nobel and Schultzberg, 1995;
Tingsborg et aI., 1997). The Il-1-related cytokine, Il-18 (also known as Il-1y), is
also synthesized within the rat adrenal cortex (mainly in the zonas reticularis and
fasciculata) and is strongly induced by acute cold stress (Conti et aI., 1997).
Rat adrenal gland extracts contain Il-6 mRNA which is markedly induced 2 h
after lPS administration (Gadient et aI., 1995; Muramami et aI., 1993; Schobitz
et aI., 1993). The zonas fasciculata and reticularis secrete small amounts of
TNF-a and Il-6, but the primary source of Il-6 in the rat adrenal is the zona
glomerulosa (Judd and Macleod, 1991; Judd and Macleod, 1992; Judd and
Macleod, 1995; Judd et aI., 1990). The secretion of Il-6 from adrenal
glomerulosa cells is stimulated by lPS, Il-1a and Il-1j3 (Judd and Macleod,
1992; Judd and Macleod, 1995; Judd et aI., 1990). In addition, the secretion of
Il-6 from these cells is enhanced by protein kinase C (PKC) activators,
ionomycin, prostaglandin E2, forskolin and angiotensin II (Judd and Macleod,
1991; Judd et aI., 1990).
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The above data clearly indicate a relationship between these stress cytokines
and the adrenal gland itself; however, it does not shed light on any possible
interaction between them and GC production or secretion. Some in vivo studies
have indicated a significant effect of exogenous cytokines on GC secretion in the
adrenals, but the physiological relevance of these effects is doubted (Roh et aI.,
1987; Andreis et aI., 1991; Gwosdow et aI., 1992; Mazzocchi et aI., 1993). One
reason cited is that the doses required to observe direct effects of, for example,
IL-1P stimulation of adrenal corticosterone secretion in vivo have been extremely
high (35 ~g/rat) (Roh et aI., 1987). As noted by Turnbull and Rivier, it seems
unlikely that a direct action of a cytokine on the adrenal can account for the rapid
in vivo effects of administered cytokines on plasma GC concentrations (Turnbull
and Rivier, 1999). Also, an alternative role for the cytokines could be to influence
GR expression, which is the topic of the next section.
2.5.3.3 Cyfokine regulation of GR levels and peripheral effects
Several studies on GR have shown that in vivo and in vitro administration of pro-
inflammatory cytokines modulates GR levels (i.e. influences GR resistance)
(Betancur et aI., 1995; Davia et al., 2003; Masera et aI., 2000; Falus et aI., 1995).
For the purpose of clarity, cytokine effects on GR levels and/or binding capacity
are mentioned separately from and before cytokine effects on GR-mediated gene
regulation are discussed.
Cytosolic GR levels were shown to be up-regulated in IL-1a-treated L929 cells in
the absence of dex (Pariante et al. 1999). In vitro treatments with IL-1-inducers,
endotoxin and lipopolysaccharide (LPS), or with IL-1p have also resulted in
increased GR availability for ligand assessed using e.g. whole cell uptake binding
method (Falus et aI., 1995 - CESS cells, U937 cells, HepG2 cells; Verheggen et
aI., 1996 - BEAS S6 cells and BEAS 2B celis); whereas in vivo treatments
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resulted in decreased GR maximal binding capacity when radioligand binding
assay was used (Liu et ai., 1993).
Pariante et al. demonstrated that 24 h treatment with IL-1a inhibits dex-induced
translocation of the GR from cytoplasm to nucleus in L929 cells (Pariante et al.
1999). In the same cells, they also showed that 24 h pretreatment with IL-1a or
24 h coincubation with IL-1a led to significant reduction in dex-induced GR-
mediated gene transcription, an effect reversed by IL-1ra. One study, in contrast,
has shown that in vitro treatment with TNF-a has a stimulating effect on GC-
induced transcriptional activity of GR (assessed using radioligand binding) in L-
929 cells (Costas et ai., 1996). These experiments involved cells that were
chemically shocked after they were transiently transfected with a MMTV-CAT
plasmid (Costas et ai., 1996), which is a method that has been used before to
measure activation of the GR (Hollenberg & Evans, 1988). Chemical shock is
known to increase GR function; therefore, such manipulation confounds
interpretation of the results (Sanchez et ai., 1994). It is, therefore, a fair
conclusion that IL-1 or IL-1-inducers up-regulate GR levels and/or binding
capacity after exposure to stressors other than chemical shock. On the other
hand, the studies mentioned above support the concept that cytokines negatively
modulate GR transactivation.
In the case of endotoxin, resistance to the inhibitory effects of Dex on
corticosterone secretion has been shown (Weidenfeld and Yirmiya, 1996). In vivo
treatment of mice and in vitro treatment of a hepatoma cell line with IL-1a and -p
has been found to decrease GC-stimulated induction of PEPCK, the enzyme
responsible for synthesis of phosphoenolpyruvate during gluconeogenesis (Hill et
ai., 1986; Hili et ai., 1988; McCallum et el., 1988). The degree of maximum
inhibition of induction of this enzyme was comparable to the percent inhibition of
GR-mediated gene transcription found in the study of Pariante et al. (McCallum
et al., 1988; Pariante et al., 1999). From this it is evident that IL-1 has been
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studied more intensively than IL-6, which necessitates investigation into the role
that IL-6 plays in regulation of GC action.
To my knowledge, three in vitro studies have investigated the direct effects of IL-
6 on GR. It has been shown that IL-6 up-regulates GR in Kaposi's sarcoma,
lymphoid and osteoblast-like cells (Guo et al., 1996; Rakasz et al., 1993; Dovio et
al., 2001). One group thus far focused on an in vivo investigation into the IL-6-GR
interaction and found that IL-6 has a direct stimulatory effect on neuronal GR (in
dorsal horn of spinal cord) levels in rats (Wang et al., 2004). This study, focusing
on a central interaction, stimulated our interested in studying the same interaction
peripherally, especially after exposure to psychological stress.
Since glucocorticoid resistance has been discussed before, it is imperative to
briefly consider such resistance in light of the involvement of stress in the
inflammatory response.
2.5.4 Inflammation-based glucocorticoid resistance
In their publication on chronic psychological stress, Miller et al. proposed a
glucocorticoid-resistance model in an attempt to explain the impact of stress on
inflammatory conditions (Miller et aI., 2002). The basic premise of this model is
that chronic stress diminishes the immune system's sensitivity to glucocorticoid
hormones that normally terminate the inflammatory response (Miller et al., 2002).
In more detail, the notions of this model are as follows (Miller et al., 2002):
a) Chronic stress elicits secretion of the hormonal products of the HPA and
sympathetic adrenal medullary (SAM) axes.
b) Continued high exposure to these hormones cause white blood cells
(WBC) to mount a counter-regulatory response and down-regulate the
expression and/or function of receptors responsible for binding GC
hormones.
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c) This receptor down-regulation diminishes the immune system's capacity to
respond to cortisol's anti-inflammatory actions.
d) Depending on the extent of the receptor down-regulation, inflammatory
processes may flourish and the course of the disease may subsequently
worsen.
These studies provided tentative proof for several notions of the glucocorticoid-
resistance model, but the authors advise against definite conclusions before
future studies replicate their findings (Miller et al., 2002). They also mention the
importance for future studies to delineate the mechanism responsible for IL-6-
induced glucocorticoid sensitivity (Miller et al., 2002). Their theory also does not
explain the adrenal gland's cytokine production and release functions. It instead
focuses only on immune cells for this function.
It is clear from the information presented in this chapter that knowledge regarding
the peripheral role and actions of IL-6 in response to psychological stress is
limited. Over the past 10-15 years it has become clear that IL-1 plays a much
bigger role in initiation of the stress response than IL-6. However, IL-6 may playa
more important role in tissue responsiveness than initially thought. We therefore
set out to design an experiment not only to investigate the function of circulating
IL-6, but also to gain a better understanding of its role in metabolic tissue-
responsiveness in vivo after exposure to mild psychological stress. Our interest is
based on whether pro-inflammatory cytokines exert any direct peripheral effects
on GC action in vivo, and the next chapter describes the methodology we
employed to investigate this.
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CHAPTER 3 ANIMAL CARE, MATERIALS AND
METHODS
This study was part of a collaborative effort.between myself and a PhD-student in
our department, Carine Smith1, whom deserves acknowledgement for
preparation of the antibody and for exposing the animals to stress and injections,
as well as for supervising the daily care of the animals according to guidelines as
set out by subcommittee C of the University of Stellenbosch. Smith also
measured the corticosterone levels, the method of which is described in her
thesis (Smith et aI., 2004), hence the decision to exclude it from this thesis.
3.1 Materialsandequipment
The anti-IL-6-antibody was obtained from R&D systems, Germany (see
paragraph 3.3). An ultra-turrax homogeniser was obtained from Janke & Kunkel
KG, Germany. [1,2,4,6,7-H]Dexamethasone ([3H]-Dex, specific activity: 83
Ci/mmol) was obtained from Amersham (TRK 645). The aprotinin, Coomassie
Bradford Reagent, a-monothiglycerol (a-MTG), a-ketoglutaric acid (a-KG),
pyridoxal-5'-phosphate (PLP), bovine serum albumin (BSA), imidazole
hydrochloride, L-glutamine (Gin), hydroxylamine (NH20H), manganese chloride
(MnCI2); adenosine-5'-diphospate sodium salt (ADP) and phosphate buffered
saline (PBS) were obtained from SIGMA (South Africa). The
phenylmethylsulfonyl fluoride (PMSF), dextran T-70, DL-dithiothreitol (DTT),
leupeptin and dexamethasone (dex) were. obtained from Sigma-Aldrich, South
Africa. Saarchem and Merck Laboratory Supplies (Pty) Ltd (South Africa)
supplied the sucrose, ethylene diamine tetra-acetic acid disodium salt (EDTA),
sodium molybdate dihydrate, L-tyrosine (Tyr), ethanol, potassium hydroxide
(KOH) and hydrochloric acid (HCI). The other chemicals used were
Tris(hydroxymethyl)aminomethane (GR buffer substance or Tris buffer, Merck,
1 see Smith, 2004.
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South Africa), Tris-HCI (Merck KGaA, Germany), activated charcoal (Fluka),
scintillation fluid (Zinsser Analytic), di-potassium hydrogen orthophosphate
(K2HP04, Merck, Darmstadt, Germany), ferric chloride (FeCb, NT Laboratory
Supplies (Pty) Ltd, South Africa) and trichloracetic acid (TCA, Sigma Diagnostics,
Inc., USA).
3.2 Experimentalanimals
Forty (40) male Wistar rats were used in this study because the oestrus cycle in
female rats causes changes in hormonal profiles, which may confound results
pertaining to corticosterone levels. Rats were housed in standard rat cages and
fed rat chow and tap water ad libitum. Temperature in the housing facility was
controlled at 21°C and lights set to a 12-hour light/dark cycle (lights on at 7 am).
Rats were bought from a nearby breeding facility (University of Cape Town),
weighed and earclipped for identification, and allowed 3 weeks to acclimatize
before initiation of the study protocol. During the acclimatization they were
handled and weighed once per day (7 times per week) to accustom them to this
procedure. No more than five (5) rats were housed together in a standard cage.
3.3 Preparationof anti-IL-6antibody treatments
An antibody raised in goats immunised with purified E.coli-derived recombinant
rat IL-6 (AF506, R&D Systems, Germany) was used as intervention treatment in
this study. 100 ug Iyophilised antibody was reconstituted with 1 ml sterile PBS,
according to manufacturer's instructions, to yield an antibody concentration of 0.1
mg/ml. This stock solution was further diluted in sterile PBS to yield a final
concentration of 2 ug/ml, so that an injection of 0.5 ml per day would result in a
dose of 1 ug/rat/day of anti-IL-6 antibody, in accordance with the manufacturer's
indicated neutralisation dosage, as well as with previous studies (Hogan et al.,
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2003; Arruda et a/., 2000). This solution was kept at 4 °C for the duration of the
protocol (stable for one month at this temperature, according to manufacturer).
3.4 Intervention
For the intervention, the rats were divided into four experimental groups of 10
rats each: control placebo (CP), control antibody (CA), immobilisation placebo
(lP) and immobilisation antibody (lA). Body mass measurements (taken at 08:00
am each morning) were recorded from 4 days prior to application of the first
stress treatments, during the 4 days of the intervention as well as on the morning
of sacrifice. Placebo rats (CP and lP) were injected intraperitoneally with 0.5 ml
of sterile saline (0.9% NaCl) once per day, and antibody rats (CA and lA) were
injected intraperitoneally with 0.5 ml of anti-IL-6 antibody solution (1 !lg/day),
once per day, prepared as described above. The injections were given 30
minutes before each bout of immobilisation stress. The stressed groups were
subjected to immobilisation stress once per day, which was achieved by
immobilising the rats (from 09:00 to 11:00 am) in immobilisation chambers
(dimensions: 20 x 8 x 8 cm) for 2 hours. Both the injection treatment and
immobilisation stress protocols lasted 4 days, after which rats were sacrificed by
decapitation (24 h after last bout of immobilisation stress). After the rats were
decapitated and their blood collected into standard SST tubes by drainage of the
aorta (Smith, 2004), I dissected out rat skeletal muscles (gastrocnemius and
vastus) and liver, which were immediately frozen in liquid nitrogen for storage at -
80°C until used.
3.5 Sample preparation and assays
TAT activity and GR binding capacity was determined in the liver and vastus
muscles, whereas GS activity was determined in the gastrocnemius muscle. The
same vastus and liver cytosolic preparations used for determination of GR
binding capacity were also used for determination of TAT activity.
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The following sub-sections describe the preparation of tissue (3.5.1.1) for use in
the binding assays and the methodology for the assay itself (3.5.1.2), which will
be followed by description of the method for determining levels of enzyme
activities (3.5.2 and 3.5.3).
3.5.1 Radioligand binding assay to determine GR levels
3.5.1. 1 Preparation of muscle and liver cytosol
Cytosol for the radioligand binding assay was prepared according to the method
of Kalimi and Hubbard as modified by others (Kalimi and Hubbard, 1983; AI-
Mohaisen et al., 2000; Sun et al., 1999). The same areas of each of the livers
were thawed, weighed, cut into fine pieces and homogenised (using an Ultra-
turrax homogeniser) in cytosol buffer A (10 mM Tris-HCI, pH 7.5, containing 0.25
M sucrose, 0.1 mM phenylmethylsulfonyl fluoride (PMSF) and 10 Jlg/mlaprotinin)
at 4°C and at a tissue to buffer ratio of 1:2 (wtlvol), e.g. 1 g of tissue was
homogenised in 2 ml of buffer. The homogenate was ultracentrifuged at 100 000
x g for 1 hr at 4°C. The upper fatty layer was collected with a pipette before it
was discarded and the crude cytosol treated with 100 JlI of dextran-coated
charcoal (DCC: 3.75 g of charcoal and 0.375 g of dextran T-70 made up in 100
ml of 10 mM Tris-HCI, pH 7.5) for 15 min at 4°C to remove endogenous steroids
(the DCC solution was simply added to the crude cytosol after removal of the
fatty supernatant). This was followed by acentrifuqation step (3000 rpm for 10
min at 4°C). The resulting clear supernatant was referred to as 'liver cytosol' and
was subsequently used for the ensuing radioligandbinding assay after a 20-fold
dilution in cytosol buffer A. The protein concentration of the undiluted liver cytosol
was determined with the Bradford protein determination assay (Bradford, 1976).
A 5-fold dilution of each sample was made with distilled water (final volume: 60
JlI),to which 250 JlIof Coomassie brilliant Blue reagent was added and 5 minutes
allowed.for the reaction to take place. The absorbance values were determined
spectrophotometrically at 595 nm, which was used to calculate the protein
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concentration within each sample by extrapolation from a standard curve plotted
from known protein concentrations.
'Muscle cytosol' was prepared from vastus muscle in similar fashion to
preparation of the liver cytosol, except for the following alterations:
1. Cytosol buffer A was replaced with cytosol buffer B ( 10 mM Tris-HCI (pH
7.5), which contained 0.25 M sucrose, 1.5 mM EDTA, 10 mM sodium
molybdate, 5 mM on, 10 mM monothioglycerol (MTG), 2 mM PMSF, 10
~g/ml leupeptin and 10 ~g/ml aprotinin). During the optimization experiments,
the protease inhibitors were found to interfere with GR stability in the liver
cytosol, hence the use of these two different buffers, buffers A and B.
2. Both vastus muscles of each rat were pooled to measure binding affinity.
3. No dilution of muscle cytosol was necessary to determine binding capacity.
3.5.1.2 Radioligand binding assay
To determine GR binding capacity, 250 ~I cytosol (20-times diluted liver or
undiluted muscle) was incubated with 10 ~I of 400 nM [3H]dexamethasone(made
up in ethanol) in the presence (non-specific binding) or absence (total binding) of
10 ~I of 1 OOO-foidexcess of unlabelled dexamethasone (0.4 mM made up in
ethanol), in 130 ~I cytosol buffer (A for liver and B for muscle), respectively, for
24h at 4°C (AI-Mohaisen et aI., 2000). In the absence of unlabelled
dexamethasone, 10 ~I of ethanol was added instead to control for volume in total
binding samples. To separate free and GR-bound dexamethasone 100 ~I of DCC
suspension (as described above in section 3.5.5.1) was added for 10 minutes at
4°C (Beato and Feigelson, 1972). The DCC-containing sample was centrifuged
at 3 000 x g for 10 min, at 4°C. This step was followed by collecting 350 ~I of
supernatant and adding it to 3 ml scintillation fluid, in which radioactivity was
measured in a Beckmann LS 3801 scintillation counter. Control samples were
included in the experiment to check for counting efficiency (CE, the ratio between
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the number of particles or photons counted with a radiation counter and the
number of particles or photons of the same type and energy emitted by the
radiation source), ligand depletion, total radioactivity added and the ability of
DCC to remove radioactive steroid. The DCC treatment (on average) was 95%
effective; CE was calculated as 35% and ligand depletion was less than 10%.
Specific receptor binding (SB) was determined as the difference between total
receptor binding (TB) and non-specific receptor binding (NSB). The radioactive
counter expressed radioactivity levels as numeric values in counts per minute
(cpm), which in turn was converted to units expressed as fmol/mg (femtomol per
milligram) protein. Examples of calculations are also shown in Appendix A.
3.5.2 Tyrosine aminotransferase assay
The cytosol used for GR-binding (section 3.5.1.1) could also be used to
determine TAT activity in both skeletal muscle and liver. The TAT assay used in
this study is a modification of that described in various publications
(Diamondstone, 1966; Granner and Tomkins, 1970a; Schacke et aI., 2004). TAT
converts tyrosine to p-hydroxyphenylpyruvate (pHPP), in the presence of a-
ketoglutarate. The TAT assay depends on the alkali-catalyzed conversion (by
adding KOH) of the reaction product, pHPP, to p-hydroxybenzaldehyde (pHBA)
and oxalate. This reaction is indicated below and the assay explained further:
TAT
tyrosine + a-ketoglutarate ~
PLP
p-hydroxyphenylpyruvate + L-glutamate
p-hydroxybenzaldehyde + oxalate
The absorbance of pHBA was measured at 330 nm.
Stellenbosch University http://scholar.sun.ac.za
60
The TAT-reaction mixture for one sample consisted of (i) 0.8 ml of 7 mM tyrosine,
made up in 125 mM K2HP04 buffer at pH 6.8, (ii) 20 ,....1 of 500 mM a-
ketoglutarate (a-KG) made up in dH20, and (iii) 10 ,....1 of 5 mM pyridoxal-5'-
phosphate (PLP) made up in dH20. The liver cytosol samples were diluted a
1DO-foldin the K2HP04 buffer containing 5 mg/ml bovine serum albumin (BSA), 1
mM EOTA and 1 mM dithiothreitol (On). The muscle samples were not diluted
for TAT activity determination. After the tyrosine (800 ,....1), PLP (10 ,....1) and a-KG
(20 ,....1) were added to 4 microcentrifuge tubes (Ieppies'), 100 ,....1 of the cytosol
(liver or muscle) was added to 3 eppis. Three (3) eppies were placed in a 3TC
waterbath for 10, 20 and 30 minutes, respectively. After the indicated amounts of
time, 70 ,....1 of 10 N KOH (potassium hydroxide) was added to these three eppies
to stop the reaction in which tyrosine was converted to pHPP.
Spectrophotometric analysis against a blank sample was performed 30 minutes
after the KOH had been added, to allow for conversion of pHPP to pHBA. The
blank sample was made by adding the KOH to the reaction mixture before the
addition of cytosol to the fourth eppi. TAT activity was calculated by using a
molar extinction coefficient of 19900 M-1cm-1 for pHPP (Oiamondstone, 1966).
One unit of enzyme activity is the quantity that catalyzes the formation of 1 urnole
of pHPP per minute at 3TC. Calculations are shown in Appendix A. Results are
expressed as units per milligram of protein per hour (U/mg prot/h).
3.5.3 Glutamine synthetase
The method of GS activity determination was performed in the rat gastrocnemius
muscle according to the methodology of Meister, as modified by others (Meister,
1985; Minet ef a/., 1997; Machado ef a/., 2001), which measures the formation of
y-glutamyl hydroxamate from glutamine, as illustrated in the reaction scheme
below:
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GS
glutamine + hydroxylamine ¢:> y-glutamyl hydroxamate + NH4+
NaAs04
Mn++
ADP
3.5.3.1 Sample preparation
The muscle was thawed and placed in 9 volumes of 50 mM imidazole, pH 6.8, at
4°C. The tissue was cut into finer pieces with a pair of scissors before it was
homogenized with the ultra-turrax. The homogenate was centrifuged at 4500 x g
for 15 min, at 4°C, and the supernatant was used for the enzyme assay. Protein
determination was performed by using the Bradford Protein Determination
Method (Bradford, 1976), as described in section 3.5.1.1.
3.5.3.2 GS assay
For determination of GS enzyme activity, the following reaction mixture was
prepared in two 5 ml tubes (one tube serving as blank): 200 ul of 250 mM
imidazole chloride, pH 6.8; 100 ul of 500 mM L-glutamine (L-Gln) made up in 50
mM imidazole, pH 6.8; 200 !-lI of 125 mM hydroxylamine (NH20H) made up in
dH20; 100 !-lI pf 250 mM sodium arsenate (Na2HAs04) and 200 !-lI of 10 mM
manganese chloride (MnCI2) (both solutions made up in dH20). The cytosol (100
ul) and 100 !-lI of 1.6 mM freshly prepared ADP (in this order; ADP made up in
dH20) were added to the active tube just before it is placed in a 3TC water bath
for 25 minutes (the blank sample is incubated at 3TC as well). No ADP is added
to the blank tube (thus, the blank contains the total incubation mixture except for
the ADP - dH20 is used to fill up this volume). The reaction is stopped by addition
of 2 ml stop solution (2.42% FeCb and 1.45% trichloracetic acid in 1.82% HCI).
Insoluble material is removed by centrifugation (4500 x g for 5 min) and the
absorbance of the supernatant was measured at 540 nm to quantify the
formation of y-glutamyl hydroxamate, for which a molar extinction coefficient of
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1.08 M-1cm-1 was used (Montanini et aI., 2003). GS activity is expressed as
nmol/min/g prot (nanomoles per minute per gram protein). Calculations are
shown in Appendix A.
3.6 Statistical analysis
Data were analysed using GraphPad Prism (version 4.00, GraphPad Software,
San Diego, California, USA). The values were calculated as means ± SEM for
each data set. For analysis of the main effects of either immobilisation stress or
anti-IL-6-antibody injections, data were analysed by a two-way ANOVA and
Fischer's post-hoc test. To determine whether any interaction occurred between
the two experimental factors (antibody vs. stress), the same statistical method
described above was used. Interaction indicated that the effects of these two
factors were significantly additive or counteractive. Correlation analyses were
performed using Pearson's correlation coefficient. For all the data, p-values at
least <0.05 were considered significant.
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CHAPTER4 RESULTS AND DISCUSSION
Psychological stress has been shown to induce the secretion of glucocorticoids
(GCs) and cytokines (Turnbull and Rivier, 1999). Current paradigms include a
bidirectional communication between GCs and cytokines (Maier, 2003), however,
few studies have investigated the blocking of a particular cytokine and the
subsequent effects on the physiological response to stress. In addition, few
studies have investigated the effects of cytokines on the tissue responsiveness to
GCs.
In the current study we sought to investigate the effect of blocking the action of
IL-6, by means of an anti-IL-6-antibody injection, on the stress response elicited
in Wistar rats by a mild chronic psychological stressor. We specifically chose to
investigate the effects of IL-6 because it has been shown that mild psychological
stress in rats induces the production of IL-6 (LeMay et al., 1990; Zhou et al.,
1993). In the study by Zhou et aI, the elevation in plasma IL-6 occurred despite
no sign of endotoxin, tissue damage or inflammation, all of these being
conditions which are expected to increase IL-6 levels (Zhou et aI., 1993). The
actions of IL-6 have been investigated before by using an anti-IL-6-antibody (IL-
6-Ab) in an osteoblast cell culture system (Masera et al., 2000), which was one of
only a few studies which studied the effects of a cytokine on tissue responses to
GCs. Also, this study showed specific interest in GR levels, and since we were
also interested in the expression of GR after exposure to psychological stress,
we decided to employ the IL-6-Ab approach in vivo. Other in vivo studies on the
interactions between IL-6 and the HPA axis have all used the approach of
knockout-studies in mice (Manfredi et al., 1998; Turnbull et al., 2003). Although
that approach is valuable, the effect of neutralising the cytokine is not limited only
to the time period of interest, which further motivated the use of the anti-IL-6-Ab
in this study.
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To elicit a mild chronic psychological stress, we chose an intervention that
consisted of a brief immobilisation (2 hours) each day for 4 consecutive days.
Previous studies have shown that 3 days of mild psychological stress (2-3
hours/day) is sufficient to induce significant loss of body mass in stressed
animals (Harris et ai., 1998; Harris et ai., 2002; Hu et ai., 2000; Rybkin et ai.,
1997), hence our decision to apply immobilisation stress for 2 h each day. Also, it
was shown that the peak level of serum corticosterone was reached within 60
min of immobilisation stress and lasted as long as the experimental duration (Hu
et ai., 2000). We applied stress between between 9 AM and 11 AM. This specific
time period was chosen because (1) it prevents a confounding influence of
circadian variation in plasma corticosterone levels from day to day, and (2)
plasma corticosterone levels are lowest in the morning (Hu et ai., 2000).
Specifically, as indicated in Chapter 3, 40 rats were divided into 4 experimental
groups (n=10 for each group): CP, control placebo; CA, control antibody; lP,
immobilised placebo; lA, immobilised antibody. The immobilised groups were
returned to their normal housing after each bout of immobilisation stress. The
antibody groups received anti-IL-6-antibody injections, which were administered
intraperitoneally.
As evident by the cited literature in Chapter 2, much work has been done that
confirms GC-based inhibition of cytokine action, particularly in the brain. Also, the
effect of cytokine action on the HPA axis has been investigated intensively.
However, the physiological implications of increased IL-6 levels after stress
remain largely unknown, especially at the level of metabolic tissue
responsiveness to GCs. Due to the proven relationships between certain
parameters and the stress response in rats, we chose to measure the following
as indicators of stress: (i) body mass change (Harris et ai., 2004), (ii) serum
corticosterone concentrations (Harris et ai., 2002), (iii) GR binding capacity (e.g.
AI-Mohaisen et ai., 2000; Hu et ai., 2000) and (iv) enzymatic activities of TAT (AI-
Mohaisen et ai., 2000) and GS (e.g. Max, 1990; Max et ai., 1988). Measurements
for (iii) and (iv) were performed in liver and muscle tissue because these are both
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organs that have been shown to contain both GR and TAT activities (AI-
Mohaisen ef al., 2000). In fact, most of the in vivo work relating to GR and TAT
has been done in muscle and/or liver and therefore other types of tissue were not
considered. For example, adipose tissue plays a central role in energy and fuel
metabolism, but the scope of this investigation does not permit a discussion on
the role of adipose tissue in metabolism.·GS has been shown to exhibit GC-
induced activity in the muscle (Labow ef al., 1999), hence our decision to
measure GS in skeletal muscle. In context of this thesis, two specific amino acids
are of interest: (1) glutamine is produced from glutamate (catalysed by GS) and
is released from the muscle; (2) tyrosine (especially in the liver) is catabolised to
fumarate and acetoacetate, which form substrates for gluconeogenesis (Chapter
2). Figure 4.1 illustrates the pathways in which these amino acids feature. What
follows. is the presentation of results obtained during the course of the
intervention described above.
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Figure4.1 A simplified illustration of the metabolic pathways in which
glutamine synthetase (GS) and tyrosine aminotransferase (TAT) are
involved. During stress, muscle protein is catabolised to amino acids. GS
catalyzes the reaction in which glutamine (Gin) is formed from glutamate (Glu).
The Gin is used by the intestines and kidneys (acid/base regulation). TAT
catalyzes the reaction in which tyrosine is metabolised to 4-
hydroxyphenylpyruvate (not shown), which is ultimately catabolised to
acetoacetate (oxidized by extrahepatic tissues) and fumarate (converted to
oxaloacetate which is fed into the citric acid cycle). Adapted from Salway, 1994.
Abbreviations: a-KG, alpha-ketoglutarate; NH/, ammonium; Gin, glutamine; Glu,
glutamate; AD(T)P, adenosine di(tri)-phosphate; Pi, inorganic phosphate; GOH,
glutamate dehydrogenase.
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4.1 Body mass and corticosterone levels
It is known that chronic stress generally results in a decrease in body mass (Hu
et aI., 2000; Alexandrova & Farkas, 1992) and an increase in corticosterone
concentrations, despite the use of diverse stressors for varying durations (MOnck
et aI., 1984; Herman et aI., 1997; Sapolsky et al., 1984).
The body mass of each rat was measured every day at 8 AM (1 h before the
stress regime) on the 4 days prior to the start of the stress intervention, and on
the 4 days during the intervention as well as on the morning of sacrifice, which
was 24 hours after the last bout of immobilisation stress. Results are expressed
as the average percentage change in body mass of each group (± standard error
of the mean, S.E.M.) over two periods. The 'before' period includes the masses
obtained before the intervention (4 days) while the 'after' period includes the
masses obtained during the intervention (4 days) plus 24 hours after the final
bout of stress (Fig 4.2A). We chose this method of presentation since the rats
were still slowly gaining body mass in the 'before' period.
As expected, the immobilised rats lost a significant percentage of body mass
when compared to controls (main effect of immobilisation - post hoc comparisons
are presented in Fig 4.2A; CP vs lP, P<O.01; CA vs lA, P<O.001). This is in
agreement with reports by other authors, confirming the notion that chronic stress
results in a decrease of body mass (Hu et aI., 2000; Alexandra and Farkas,
1992). Although the protocol of this study allowed only 4 days of mild
psychological stress, the stress was severe enough to induce significant loss (3-
4%) of body mass in the Wistar rats. This correlates well with a report by Harris
et aI., which indicated a 5-10% loss of body mass in Sprague-Dawley rats after
exposure to restraint stress for 3 hours per day over 3 days (Harris et aI., 1998).
Restraint stress is more severe than immobilisation stress and the protocol lasted
an hour longer than ours, thus accounting for the greater body mass loss in those
amimals.
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Figure 4.2. The effect of immobilisation stress and anti-IL-6-antibody
treatment on the change in body mass of Wistar rats. (A) The average
percentage of body mass change in the 4 different experimental groups used.
The percentage change in body mass of male Wistar rats was averaged for 4
days prior to the start of the intervention protocol (BEFORE) and during the 4
days of the intervention protocol plus the day of sacrifice (AFTER). Prior to day 1
of the intervention, no difference in body mass were found between the different
groups. After the intervention, the stressed groups lost weight significantly when
compared to controls. (B) Absolute body mass change per day in the two groups
of stressed rats (lP and lA). Despite no detectable statistical difference, it seems
that group lP lost weight much faster than groups lA, which is reflected on the
sizes of the bars on days 2-3 of the intervention. All results are expressed as
means ± SEM and statistics were performed using 2-way ANOVA with Fischer
post test analysis (**P<O.01; #P<O.001). Abbreviations: CP, Control Placebo; CA,
Control Antibody; lP, 1mmobilisation Placebo; lA, Immobilisation Antibody.
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Both repeated restraint stress (Harris ef al., 2002) and chronic overproduction of
IL-6 in transgenic mice (Tsujinaka ef al., 1995) have been shown to
independently cause muscle mass loss and reduction in body mass of rats. In
our case, blocking the action of IL-6 by anti-IL-6 antibody treatment had no
significant effect on the percentage change in body mass between the placebo-
treated and antibody-treated rats in the control groups (no main effect of antibody
and no post hoc differences - Fig 4.2A; CP vs CA). Similarly, the antibody
treatment had no significant effect on the change in percentage body mass of the
stressed group (Fig 4.2A; lP vs lA), both of which lost a similar amount of body
mass over the course of the intervention.
Closer inspection, however, revealed that, although groups lP and lA showed no
difference in accumulated body mass loss during and after the intervention, the
time frame of the body mass loss might have been influenced by the antibody
injection (Fig 4.28). When the daily loss of body mass is shown, group lA does
not show the same amount of weight loss on days 2 and 3 when compared to
groups lP. If the antibody treatment did not cause a significant effect in the
accumulated body mass loss between these stressed groups, it seemed to affect
the time frame of body mass loss in those groups (Fig 4.2B, compare body mass
loss of groups lP vs. lA, days 2 and 3). However, no significant effect could be
proved with statistical analysis, which is probably due to large variations in
absolute body mass loss between rats in the different groups.
If the mechanism of stress-induced body mass loss was reliant on the production
of excess IL-6, we would have expected to see a lesser change in body mass in
the lA group compared to the lP group. Instead, the mean accumulated body
mass change for the stressed group lA (-3.61±0.83%) was slightly higher (but not
significantly so) than for the stressed placebo group (lP, -3.16±0.44%). However,
the antibody treatment did retard body mass loss in group lA (Fig 4.2B). This
suggests that IL-6 plays a role in body mass loss especially during the earlier
response (days 2-3) to a chronic stress. The fact that the lA group did lose body
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mass by day 4 could be due to a slower acting mechanism separate from IL-6, or
it is possible that the rats began to produce excess IL-6 that was no longer
neutralised by the antibody.
The corticosterone concentrations of the rats in the different groups were
measured 24 hours after the last bout of immobilisation stress and are shown in
Figure 4.3. Immobilisation stress caused a significant 2-fold up-regulation of
corticosterone concentrations in the serum of rats in the stressed placebo group
(main affect of stress with one significant post hoc test result - Fig 4.3: CP vs lP,
P<O.01), agreeing with results presented by AI-Mohaisen et aI., who showed that
immobilisation in rats caused a 2- to 3-fold increase in serum corticosterone
concentrations (AI-Mohaisen et aI., 2000). Although there was a significant main
effect of immobilisation stress on corticosterone concentration, there was also an
interaction effect with the antibody resulting in no significant effect of stress as
measured in the serum of rats of group lA compared to group CA. It was
previously reported that IL-6 causes up-regulation of corticosterone
concentrations via influences at different levels of the HPA axis, namely the
hypothalamus, pituitary and adrenal glands (Navarra et aI., 1991; Zhou et aI.,
1993; Muramani et aI., 1993; Schobitz et al., 1993; Spangelo et aI., 1990). Our
results support a role for IL-6 in increasing corticosterone concentrations of rats.
Although the increase of corticosterone levels in group lA does not reach
significance, it shows a slight increase when compared to the non-stressed
groups (CA and CP). When taken into account that this slight increase is in the
absence of IL-6, we thus speculate that IL-6 may be required for a full-blown
stress response.
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Figure 4.3 The effect of immobilisation stress and anti-IL-6-antibody
treatment on the serum corticosterone levels of male Wistar rats. Serum
corticosterone concentrations in control and stressed groups of the Wistar rats
were measured by enzyme-linked immunosorbent assay (ELISA) kits. Results
are expressed as means ± SEM and were analysed using two-way ANOVA with
Fischer post tests (**P<O.01). Abbreviations: CP, Control Placebo; CA, Control
Antibody; lP, Immobilisation Placebo; lA, ImmobilisationAntibody.
In summary, our results (showing that the immobilisation protocol decreased
body mass and increased corticosterone levels of male Wistar rats) indicate that
our intervention was indeed eliciting a stress response and that IL-6 may be
required for an early and a full-blown activation of the stress response, certainly
as measured by corticosterone levels.
4.2 Glucocorticoid receptor binding
Glucocorticoid action is mediated via its receptor in the cytoplasm of responsive
cells and the magnitude (maximal response) and potency (EC50) of the response
is dependent on receptor levels (Simons & Thompson, 1982). Several authors
have addressed the issue of studying the effects of stress on GR levels, but
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results are conflicting (see AI-Mohaisen et ai., 2000 for discussion on these
conflicting reports). Thus we decided to measure GR levels in the liver and
muscle of our experimental groups of rats. Tissue was harvested at the same
time as blood samples from which the corticosterone concentrations were
measured (24 hours after the last bout of immobilisation stress). The liver and
muscle were chosen because the two metabolic enzymes we studied, GS and
TAT, function principally in these organs during stress (Labowet ai., 1999; Minet
et ai., 1997; Rosen and Milholland, 1963; Rosenberg and Litwack, 1970). To
determine the levels of GR in rat liver and muscle we measured the extent of
agonist (dexamethasone) binding, using radioligand binding assays. The results
are presented in figures 4.4A (muscle) and 4.4B (liver).
The GR binding capacity in group CP of both liver (36.36±2.53 fmol/mg protein)
and muscle (6.41 ±0.45 fmol/mg protein) are lower than values reported by other
authors (AI-Mohaisen et ai., 2000; Sun et ai., 2002). A possible explanation
involves handling of the animals. All the rats were given injections (either placebo
or IL-6-Ab), which might have served as a stressor in itself and therefore could
have led to down-regulation of GR levels. Handling of rats, in general, was
shown tb be perceived by the rodents as stressful (Gadek-Michalska & Bugajski,
2003), which leads to prolonged feedback inhibition of HPA axis activity even
before the start of experimental interventions. Alternatively, other studies used
different strains (e.g. Sprague-Dawley, Fischer 344 or Lewis rats vs. our Wistar
rats), which have considerable differences in glucocorticoid responses to stress
(Dhabhar et ai., 1993).
Stellenbosch University http://scholar.sun.ac.za
73
A B
#
*
Ct # Ct
1#
.......... ..u
c c
en .- * en· -.s :!: II 1 .s ::IE"'Ow "'Ow
cCI) 'kit CCI)
.a +1 I .a +1O::en O::en
(!)E (!)E- -0 0
E E- -
CP CA lP lA CP CA lP lA
Figure 4.4 The effect of immobilisation stress and anti-IL-6-antibody
treatment on the GR levels in (A) skeletal muscle and (B) liver of Wistar
rats. GR levels were determined by dexamethasone binding capacity as
measured by radioligand binding assay. Both stress and the anti-IL-6-antibody
significantly down-regulated the GR levels. Results are expressed as means ±
SEM. Statistical analysis: Two-way ANOVA with Fischer's LSD as post test.
(*P<O.05; **P<O.01; #P<O.001). Abbreviations: CP, Control Placebo; CA, Control
Antibody; lP, Immobilisation Placebo; lA, ImmobilisationAntibody.
Immobilisation stress caused a significant decrease in skeletal muscle and liver
GR binding capacity (main effect of stress with post hoc results presented in Fig
4.4A and 4.4B; CP vs. lP, P<0.0001; CA vs. lA, P<0.0001). Many authors (e.g.
Omrani, 1980; Sapolsky 1984; Shirwany, 1986) have previously presented
similar results (decrease in GR binding capacity), whereas others have reported
increases in GR binding capacity and amount of GR in studies where the effect
of chronic stress was investigated (Hu et ai., 2000; AI-Mohaisen et ai., 2000; Sun
et ai., 2002). In both the liver and muscle tissue, we measured between 17-70%
decreases in GR levels between groups CP and all the other experimental
groups. This correlates with previous reports that indicated decreases in GR
,,'
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levels of between 25-50% (Sapolsky et aI., 1984 - brain tissue; Omrani et aI.,
1980 - hepatic tissue; Shirwany et aI., 1986 - hepatic tissue).
Discrepancies in results between studies have been attributed to factors such as
use of different techniques and animals, duration and intensity of stress and
different types of tissues under investigation. The receptor assay we used
measured the total and non-specific binding capacity of the receptors in the
cytosol extracts and therefore we could calculate the specific binding capacity of
the receptors to dexamethasone. Two reports that indicated increases in binding
activity of GRs differ from ours in the following respects: (1) we investigated the
effects of a mild chronic stress whereas Sun et al. (Sun et aI., 2002) studied the
effect of sepsis (a more acute and extreme stress) on muscle GR expression and
binding; and (2) AI-Mohaisen et al. (AI-Mohaisen et ai., 2000) used a new
approach to measuring GR in liver tissue that could not be repeated in our
laboratory (despite several attempts), which makes it difficult to interpret their
results in comparison to our own.
The antibody treatment caused a significant down-regulation of GR binding
capacity in both skeletal muscle and liver, under basal (main effect of antibody
treatment with post hoc results presented in Fig 4.4A and Fig 4.48: CP vs. CA,
p<0.05) and stressed conditions (main effect of stress with post hoc results
presented in Fig 4.4A and Fig 4.48: lP vs. lA, p<0.01). It has been shown that IL-
6-antibody administration significantly decreased GR number in vitro in
osteoblast cell lines, abolishing the up-regulatory effect of IL-6 (Masera et ai.,
2000; Dovio et ai., 2001). The results of our study are the first to demonstrate this
effect invivo and to support the in vitro findings of Masera et al. (2000) and Dovio
et al. (2001). Further supportive evidence was provided by authors who did not
use anti-IL-6-antibodies in their studies, but who showed that IL-6 up-regulates
GR in both Kaposi's sarcoma and lymphoid cells (Guo et ai., 1996; Rakasz et ai.,
1993).
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4.3 Enzymatic activities
In Chapter 1 it was mentioned that, during stress, GCs induce the expression of
many enzymes, basically to promote the mobilisation of amino acids (from
protein degradation in the muscle) for the purpose of serving as energy
substrates for other cells and for gluconeogenesis in the liver. Such GC-
responsive enzymes, whose genes contain GREs, are typically found in GC
target tissues and are used to indicate enzymatic responses to stress. The two
enzymes we chose to study were tyrosine aminotransferase (TAT) and glutamine
synthetase (GS). Traditionally, TAT activity is measured in the liver (Kenney,
1959; Rosenberg and Litwack, 1970), whereas substantial GS activity can be
measured in skeletal muscle and lungs (Labowet aI., 1999;Abcouwer, 1995).
4.3.1 Tyrosine aminotransferase
TAT activity was determined in skeletal muscle and liver by measuring the
absorbance of a reaction mixture containing p-hydroxybenzaldehye (pHBA),
which was formed after the alkali-catalysed conversion of p-
hydroxyphenylpyruvate (pHPP) (Diamondstone, 1966; see Chapter 3). Results
are shown in Fig 4.5.
In skeletal muscle and liver, the immobilisation stress caused a significant up-
regulation of TAT activity in both the placebo-treated (main effect of stress with
post hoc results presented in Fig 4.5A (CP vs lP, p<0.001) and Fig 4.5B (CP vs
lP, p<0.0001» and antibody-treated rats (main effect of antibody treatment with
post hoc results presented in Fig 4.5A (CA vs lA, p<0.001) and Fig 4.5B (CA vs
lA, p<0.0001». The different percentage increases of TAT activity are shown in
Table 4.1.
The increases in TAT activity are in agreement with reports that also indicate
increases in hepatic TAT activity after GC treatment (DuBois et aI., 1995;
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Ramakrishnan et aI., 2002) and immobilisation stress (AI-Mohaisen et aI., 2000).
In our case, however, a higher fold-induction was measured (Table 4.1),
especially in the liver after immobilisation stress. AI-Mohaisen et al. reported a
1.6-fold increase in hepatic TAT activity after immobilisation stress (AI-Mohaisen
et aI., 2000), whereas we measured 2.7- and 2.6-fold inductions in the stressed
groups. In the other reports mentioned, 7- and 6-fold inductions of TAT activity
were reported following hormone administration (Ramakrishnan et aI., 2002;
DuBois et aI., 1995; Chesnokov et aI., 1990).
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Figure 4.5 The effect of immobilisation stress and anti-IL-6-antibody
treatment on the TAT activity in (A) skeletal muscle and (B) liver of Wistar
rats. TAT activity was determined by following the non-enzymatic conversion of
p-hydroxyphenylpyruvate to p-hydroxybenzaldehyde. Results are expressed as
means ± SEM, n = 39. Statistical analysis: Two-way ANOVA with Fischer's LSD
as post test. (*P<O.05; **P<O.01; #P<O.001). Abbreviations: CP, Control Placebo;
CA, Control Antibody; lP, Immobilisation Placebo; lA, Immobilisation Antibody.
However, treatment with exogenous GCs can be considered a more extreme
intervention. More importantly, we show an effect after only 2 h/day of mild
psychological stress. Of added significance is the fact that we found changes in
TAT activity in skeletal muscle after psychological stress, since most previous
research on TAT has investigated only the liver. In our case, there is a large
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difference in the amount of TAT activity measured between these two different
tissues, which agrees with a previous study performed in mink (Prieur et ai.,
2001). We suspect that the traditional focus (with regards to TAT activity) may
have been placed on the liver due to the abundance of the TAT protein in this
organ, but it does not justify why studies on TAT activity in other tissues have
been neglected to the extent that is has been.
TABLE 4.1. Percentage and fold increases in TAT activity in skeletal muscle and
liver of Wistar rats after exposure to immobilisation stress and anti-IL-6-antibody
treatment.
Stressed groups Antibody groups
lP vs CP IAvs CA CAvs CP IAvs lP
Muscle + 58 % +47 % + 19 % + 11 %
Fold-induction 1.58 1.47 1.19 1.11
Liver + 165 % + 159 % +27 % +24 %
Fold-induction 2.65 2.59 1.27 1.24
Footnote: % Increase: calculation e.g. ((IP/CP)*100) - 100; fold-Induction: calculation e.g. IPICP
The effect of the antibody treatment on TAT activity was less pronounced
although the main effect was significant in liver (p<0.05) and tending toward
significance in muscle (p<0.08). Post hoc analysis revealed that, in both the liver
and muscle tissue, there were no statistical differences between the CP and CA
groups. In the muscle, no statistical difference was measured between the lP and
lA groups (p=0.25), however, TAT activity was different between these groups
(p<0.05) in the liver. The latter result (in the liver) indicates, therefore, that the
antibody had increased TAT activity independent of stress and that IL-6 may thus
inhibit TAT activity in vivo. In support of our results, it has been shown that IL-6c
(a recombinant IL-6 molecule) strongly reduced, in a dose-dependent manner,
expression of TAT in rat fetal hepatocyte cells (Zvibel et aI., 2004). With the
exception of this last-mentioned study, there is a general lack of in vitro data with
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regards to enzyme-responsiveness to IL-6. Our results are the first to show, in
vivo, that a direct relationship exists between IL-6 and TAT activities in adult rat
livers. More research, therefore, is necessary to establish the exact mechanisms
involved.
4.3.2 Glutamine synthetase
GS activity was determined in gastrocnemius muscle by measuring the formation
of y-glutamylhydroxamate in a reaction whereby glutamine is used as a
substrate, together with ADP and hydroxylamine (Minet et aI., 1997; see Chapter
3). Results are shown in Fig 4.6.
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Figure 4.6 The effect of immobilisation stress and anti-IL-6-antibody
treatment on GS activity in skeletal muscle of Wistar rats. GS activity was
determined by measuring the formation of y-glutamylhydroxamate in a reaction
whereby glutamine is formed from glutamate, ADP and hydroxylamine. Results
are expressed as means ± SEM, n = 39. Statistical analysis: Two-way ANOVA
with Fischer's LSD as post test. ('#P<O.001). Abbreviations: CP, Control Placebo;
CA, Control Antibody; lP, Immobilisation Placebo; lA, Immobilisation Antibody.
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The immobilisation stress caused a significant up-regulation of GS activity in both
stressed groups (main effect of stress with post hoc results presented in Fig 4.5:
CP vs lP, p<O.0001; CA vs lA, p<O.0001). These nearly-2-fold increases (CP vs
lP: 1.81-fold; CA vs lA: 1.67-fold) in GS activity are in agreement with a report
published by Vats et al. (Vats et ai., 1999), who indicated a 2-fold increase in GS
activity in Wistar rats after exposure to 7 days of chronic intermittent hypoxic
stress.
The antibody treatment caused no significant changes in GS activity in either the
control or stressed groups. Table 4.2 summarizes the effects of the intervention
on GS activity.
TABLE 4.2. Percentage and fold increases in GS activity in skeletal muscle of
Wistar rats after exposure to immobilisation stress and anti-IL-6-antibody
treatment.
Stressed groups Antibod I groups
lP vs CP IAvs CA CAvs CP IAvs lP
Muscle + 81% +67% +15% +14%
Fold-induction 1.81 1.67 1.15 1.14
Footnote: % Increase: calculation e.g. ((IP/CP)*100) - 100; fold-induction: calculation e.g. IPICP
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4.4 Correlations
Pearson's correlation analyses were performed on the different sets of results to
determine if any variables were associated with each other. This analysis was
done with the goal of obtaining possible trends in the data not otherwise seen,
but it must be cautioned that it is not common practice to correlate data of entire
groups of rats in the ways presented below. In short, the correlation analysis was
not expected to produce any meaningful biologically relevant information.
However, it is considered necessary in terms of preparation for future studies.
Significant relationships were found for the following pairs of variables that
seemed to be most significant with regards to the outcomes of our study:
A) Change in body mass (flBM) vs. all other parameters
B) GR (liver) vs. GR (muscle);
C) GR (liver) vs. TAT (liver);
D) GR (muscle) vs. TAT (muscle);
E) GR (muscle) vs. GS (muscle) and
F) TAT (muscle) vs. GS (muscle).
The change in body mass (~BM) is used as an overall parameter of organismal
stress (relationship described in A) and is related to all other parameters
measured in this study in the whole group '(Table 4.3) and in two sub-groupings
(Table 4.4). Our aim was to establish which parameters influenced flBM and to
what extent the latter was influenced by these parameters.
As seen in Table 4.3, the higher corticosterone concentration was indeed
associated with greater loss of body mass (r = -0.43, p<0.01), but by itself it is not
the main influence. GR binding capacity (in the liver) has the most significant
relationship with flBM (r = 0.68, p<0.0001), with GR binding capacity (in the
muscle) showing less, albeit still significant influence on flBM (r = 0.53, p<0.001).
Although the enzyme parameters (TAT and GS activities) showed significant
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influences on LlBM (~BM vs. TATliver,r = -0.55, p<0.001; ~BM vs. TATmuscle,r =
-0.46, p<0.01; ~BM vs. GSmuscle,r = -0.58, p<0.001), it is at least one level of
significance less than the correlation between GRliverand LlBM (r = 0.68,
p<0.0001).
Table 4.3 Correlations between the change in body mass and other measured
parameters of Wistar rats after exposure to immobilisation stress and
anti-IL-6-antibody treatment.
Parameters r-vetue
Total Group
(n=39)
Serum parameter
~BM vs. [cort] -0.43**
GR parameters
~BM vs. GRliver 0.681l'
~BM vs. GRmuscle 0.53***
Enzyme parameters
~BM vs. TATliver -0.55***
~BM vs. TATmuscle -0.46**
~BM vs. GSmuscle -0.58***
Significance: *P<0.05; **P<0.01; ***P<0.001; #P<0.0001
~BM, change in body mass; [cort], corticosterone concentration;
GR, glucocorticoid receptor binding capacity; TAT, tyrosine aminotransferase activity;
GS, glutamine synthetase activity; r, Pearson product correlation coefficient
With the GR being influenced by corticosterone and the enzymes being GR-
inducible, the question arose as to why such differences in significance are found
between serum, GR and enzyme parameters. One possible answer may relate to
the effects of the antibody - we therefore wanted to determine whether the
antibody treatment affected these relationships. For this reason we performed
similar correlation analyses on the rats that did not receive the antibody (the
'Placebo Group') as well as rats who received the antibody (the 'Antibody
Group'). The results are presented in Table 4.4.
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Indeed, Table 4.4 shows that the levels of significance in the relationships found
in the placebo group either improves (~BM vs. GRliver), declines (~BM vs.
GSmuscle.; ~BM vs. TATliver) or falls away completely (~BM vs. [cort]; ~BM vs.
GRmuscle; ~BM vs. TATmuscle) in the antibody group. It should be taken into
account that both these groups (Placebo vs. Antibody) received varying levels of
stress, namely an injection (placebo or antibody) with or without immobilisation
stress.
Table 4.4 Correlations between the change in body mass and other measured
parameters of the placebo-treated (Placebo Group) and antibody-
treated (Antibody Group) Wistar rats after exposure to immobilisation
stress and anti-IL-6-antibody treatment.
Parameters r-vetue r-vetue
Placebo Group Antibody Group
(n=20) (n=19)
Serum parameter
L18Mvs. [cort] -0.59** -0.27N::>
Liver parameters
L18Mvs. GRliver 0.65** 0.75***
L18M vs. TATliver -0.68*** 0.58**
Muscle parameters
L18Mvs. GRmuscle 0.51* -0.43N::>
L18Mvs. TATmuscle -0.74*** -0.18N'"
L18Mvs. GSmuscle -0.66** -0.51*
Significance: NS, non-signifcant ; *P<0.05; **P<0.01; ***P<0.001.
L18M, change in body mass; [cort], corticosterone concentration;
GR, glucocorticoid receptor binding capacity; TAT, tyrosine aminotransferase activity;
GS, glutamine synthetase activity; r, Pearson's product correlation coefficient
Table 4.4 clearly demonstrates that an abolishment of IL-6 activity leads to a
significant disruption of the stress response in terms of expected downstream
relationship between change in body mass and glucocorticoids, which agrees
with the hypothesis that IL-6 is necessary for the full-blown stress response. In
only the placebo groups and not in the antibody groups, significant correlations
were observed between óBM and GR levels for both liver and muscle, with the
best relationship observed for liver GR. In fact, the relationship between muscle
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GR and ~BM was no longer significant in the antibody group. A similar
observation could be made for the relationships between ~BM and TAT: these
were significant in the placebo in both tissues, but in the antibody groups the
relationship was no longer significant in muscle tissue. In contrast, the
relationship between ~BM and GS in the muscle was present in both groups,
although to a lesser extent in the antibody group. It is not clear why the muscle
would be more sensitive to the absence of IL-6, so that in this tissue expected
relationships were not seen unless IL-6 was present. A further study is needed
to support these preliminary findings and to uncover the mechanisms underlying
the observations.
Fig 4.7 illustrates relationships B-F as described at the beginning of section 4.4.
We set out to measure GR binding capacity in both skeletal muscle and liver
tissue. Since this was the first time that the GR radioligand binding assay was
employed to measure GR binding capacity of skeletal muscle tissue in our lab, it
is of added significance that the receptor levels in these tissues show such a
strong correlation (Fig 4.7A: r = 0.73, p<0.0001). Although GR has been
measured in either the one or the other tissue before (AI-Mohaisen et ai., 2000;
Sun et ai., 2002), no study to date has looked at GR expression in both these
tissues after a psychological stress intervention and therefore our results are the
first to report such a strong correlation in receptor binding capacity between
these different tissues under the specific experimental conditions of
immobilisation stress. We argue that, although skeletal muscle and liver have
different metabolic functions, similar regulatory mechanisms may be involved in
the regulation of GR expression after stress, hence such a strong relationship
between GR binding capacities of these tissues. Also, the relevance of this
posltive relationship is justified at the level of other proteins that are responsive to
GC-action in peripheral tissues.
As expected, the relationships between GR binding capacity and the activities of
the GC-inducible enzymes are all strongly negative (Fig 4.7B-D). Based on
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previous reports, we expected TAT levels to increase during and after the stress
intervention, via the increase of circulating corticosterone levels and down-
regulated GR (Dubois et aI., 1995; Vi-Li et aI., 1989). Studies that support the
decrease of GR after exposure to either stress or IL-6-Ab treatments, include the
following: Sapolsky et aI., 1984; Reul et aI., 1990; Omrani et aI., 1980; Gomez et
aI., 1996; Nishimura et aI., 2004; Masera et aI., 2000 and Dovio et aI., 2001. The
increase in TAT activity, on the other hand, is supported by the following studies:
Granner et aI., 1968; Vi-Li et aI., 1989 and Ramakrishnan et aI., 2002. Although
the in vivo TAT response (both at mRNA and enzyme activity levels) happens
rapidly after GC treatment (5.5 hours), the effects of GR regulation last much
longer, even after removal of the hormone (Dubois et aI., 1995). This explains
why we could measure an increase in TAT activity on the fifth day of our
experiment, which was 24 hours after the last bout of stress. In terms of the
effects of IL-6 on TAT activity, we suggest that IL-6 may either independently and
directly decrease TAT activity (the anti-IL-Ab increased TAT activity) or prevent
excessive increases that occur due to stress by interacting negatively with the
GC response at some level that would have downstream effects in both liver and
skeletal muscle.
In support of the first possibility are previous reports that IL-6 decreases TAT
activity in rat hepatoma FAO cells (Guzdek et aI., 1995) and that IL-6c (a
recombinant IL-6 chimera) dose-dependently reduced TAT activity in fetal
hepatocytes (Zvibel et aI., 2004). Not much work has been done on the
interaction between TAT and cytokines in vivo and therefore our work contributes
significantly in this regard.
Stellenbosch University http://scholar.sun.ac.za
Figure 4.7 Correlation analyses between different parameters in skeletal
muscle and liver of 39 Wistar rats after exposure to mild psychological
stress (immobilisation) and anti-IL-6-antibody treatment. To aid in
visualization of the distribution of the data points in each of the different
experimental groups, the groups are shown in different colours: CP, Control
Placebo (blue); CA, Control Antibody (red); lP, Immobilisation Placebo (yellow);
lA, Immobilisation Antibody (green). The correlation coefficient (r) and p-values
are shown alongside each graph. (A) GRliver vs. GRmuscle; (8) GRliver vs. TATliver;
(C) GRmuscle vs. TATmuscle; (D) GRmuscle vs. GSmuscle; (E) TATmuscle vs. GSmuscle.
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In terms of TAT activity, the liver seems to be more sensitive to regulation by IL-6
than the muscle, since a significant antibody-dependent increase in TAT activity
is measured in the liver (in the lA experimental group), but not in the muscle. TAT
protein is much more abundant in the liver than in any other organ (Prieur et ai.,
2001), which may explain the increased sensitivity of the liver to the anti-IL-6-Ab
intervention. In support of a second possible mechanism of IL-6 action is the fact
that the lA group did not have significantly elevated corticosterone (as assessed
by the post-hoc test) and also lost the significant correlation between ~BM and
corticosterone that was evident in the placebo groups.
GS activity was measured in the gastrocnemius muscle while GR binding
capacity was measured in the vastus. In order to perform optimal binding
experiments, the two vastus muscles of each rat were pooled for one data point,
hence the decision to measure GS activity in the gastrocnemius (the cytosol for
the binding experiments could not be used for the assaying of GS activity). GS
activity in gastrocnemius muscles of rats has previously been measured (Hundal
et ai., 1990) while GR expression has previously been measured in both the
vastus and gastrocnemius muscles (Czerwinski & Hickson, 1990). From this we
thought it viable to correlate the GS activity with the expression of GR, which is
shown in Fig 4.7D. Our results, as measured in gastrocnemius muscle, are
mostly according to expectations. Stress and GCs are known to increase levels
of GS activity (Vats et ai., 1999; Kom et ai., 1998), whereas increases in GS
activity has been associated with decreased GR levels (Kom et ai., 1998). In
murine astrocyte cultures, however, it has been shown that LPS inhibits GS
activity via release of IL-6, IL-1 and TNF-a, also indicating that IL-6 partially
inhibits GS activity (Hu et ai., 1994). Our results show that the anti-IL-6-Ab had
no significant effect on GS activity and that increased GS activity was due to the
immobilisation stress. The lack of an effect from the antibody can be explained
by the facts that IL-6 has been shown to work in concert with other pro-
inflammatory cytokines (such as IL-1 and TNF-a) and that high in vivo
concentrations of a particular cytokine are often necessary for a significant effect.
Stellenbosch University http://scholar.sun.ac.za
87
However, not many in vivo investigations have focused on the interaction
between GS and pro-inflammatory cytokines, which makes it difficult to interpret
our results in a more meaningful manner.
A significant relationship between the activities of TAT and GS is shown in
skeletal muscle (Fig 4.7E). Although the activities of these two enzymes were
measured separately in the vastus and gastrocnemius muscles, respectively, a
positive relationship is interpreted in terms of the total protein catabolic activity
during stress. This is the first study to indicate such a relationship, even though
both enzymes have been studied extensively. In addition, a change in TAT
activity in muscle has not been shown before since most investigations into TAT
activity have focused on the liver as the main site of TAT activity. Our interest in
this relationship is thus justified since we wanted to investigate the peripheral
responses that happen in tissues after psychological stress. When the organism
is faced with stress, glucocorticoid-induction of gluconeogenesis is known to
occur, which is important in terms of survival. At the level of tissue
responsiveness, this is related in terms of the amount of amino acids that are
needed to serve as substrates for energy production. Since GS and TAT are both
involved in amino acid catabolism, it becomes evident that such a positive
correlation in their activities is justified in terms of the general stress response.
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CHAPTER 5 SYNTHESIS, CONCLUSIONSAND FUTURE
STUDIES
The role of glucocorticoids in the stress response has been investigated for more
than 50 years and since the identification of cytokines (about 30 years ago), the
interaction between these two systems has become a separate field of scientific
endeavour. To name a consequence of this, the field of psychoneuroimmunology
(PNI) is a faster growing field of research than most others that study the link
between physiology and behaviour. IL-1 is the first interleukin that is elevated in
response to stress, but IL-6 has been identified as a mediator of IL-1 action
(Ruzek et al., 1997) and thus much attention has been placed on IL-6 as a highly
pleiotropic cytokine. The basis of our study stems from our interest in the
interaction between peripheral IL-6 and metabolic tissue-responsiveness to GCs
after exposure to mild psychological stress. To our knowledge, we are the first to
investigate in vivo tissue reponsiveness (GR expression and GR-inducible
enzyme activities in both liver and skeletal muscle) in response to treatment with
an IL-6-Ab.
Due to the 2 X 2 factor design of our experiment, we could separate the stress-
induced effects from the antibody-induced effects, in addition to separating any
interactive effects that might have occurred between them. To aid in explanation
of both factors (stress vs. antibody), both factors will be discussed separately for
each of the measured parameters as set out in Chapter 4.
Firstly, we set out to invoke a stress response in Wistar rats. Since studies on
chronic stress have traditionally utilised quite extreme protocols such as restraint
stress, we decided to investigate whether a mild psychological stress protocol
could result in a similar stress response. This regimen of mild psychological
stress resembles a more realistic form of stress experienced by humans on a
weekly basis. Since our protocol was designed to be relatively mild, we chose to
use a shorter duration. Therefore, the duration of our protocol was 4 consecutive
Stellenbosch University http://scholar.sun.ac.za
89
days. We chose the morning hours (9 AM to 11 AM) to perform our experiments,
based on information provided by Hu ef al. which indicates that the plasma
corticosterone levels are lowest during this time (Hu ef al., 2000). The same
authors also indicate that the peak level of plasma corticosterone was reached
within 60 minutes of immobilisation stress and lasted as long as the experimental
duration (Hu ef al., 2000). For this reason we also chose 2 hours/day as the
duration of the immobilisation stress sessions, which is also the duration chosen
by Hu ef al. (Hu ef al., 2000).
It has been shown that immobilisation stress causes significant reduction in body
mass of rats (Hu ef aI., 2000). The decrease in muscle mass (and consequently
body mass) is related to the increases in corticosterone levels during stress
(Herman & Cullinan, 1997). Taken together, the body mass and plasma
corticosterone levels would indicate whether or not we achieved our first goal,
namely that of eliciting a full-blown stress response. Indeed, our results show a
decrease in body mass in both stressed groups (lA and lP) as well as a
significant increase in the plasma corticosterone levels in group lP.
No significant increase in plasma corticosterone in group lA was measured
compared to both control groups (CP and CA) and group lP. Elevations in IL-6
levels, in response to physical and psychological stressors, have been shown to
lead to increases in GC concentrations, due to increases in CRH and ACTH
levels (Zhou ef al., 1993; Kronfol ef al., 1992), which explains why the antibody
treatment blocked a full-blown stress response in group lA. Thus, IL-6 is a
necessary component in GC up-regulation during mild psychological stress in
vivo.
With regard to the relationship between elevated corticosterone levels and loss in
body mass, another significant observation is the positive relationship between
these two parameters (change in body mass (~BM) vs. corticosterone levels -
see Chapter 4) in the entire group of rats and the placebo group. This
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observation supports the existing notion that the change in body mass is related
to the amount of psychological stress perceived by the individual, even if the
stressful experience is as mild as 4 consecutive days with only 2 hr/d of
immobilisation stress. This is consistent with previous reports that both increased
plasma corticosterone levels and decreased body mass are found in rats that
were exposed various kinds of stressors, for varying amounts of time (Harris ef
al., 1998; Rybkin ef al., 1997; Hu ef al., 2000; Gursoy et al., 2001). The
decreases in body mass, in most cases, were detectable after only 3 days of e.g.
restraint stress (Harris ef al., 2002). Future experiments may thus rely on body
mass changes as a marker of stress perceived by experimental animals. It is
noteworthy to mention that we do not observe the relationship described above in
the group of rats treated with antibody. We think that this may be due to the
larger number of samples that yielded non-detectable levels of corticosterone in
groups CA and lA, which on the one hand influences the correlation, but on the
other hand indicates the important role of IL-6 in the corticosterone response to
stress.
The immobilisation stress caused a most pronounced down-regulation in GR
binding capacity in both liver and skeletal muscle of the rats. This is a significant
finding, since most previous studies concentrated on either one or the other of
these tissues, but rarely both. When the GR binding capacities in both tissues
were correlated, we found strong, positive correlation coefficients. A similar
glucocorticoid regulatory mechanism may be active in both the muscle and liver
during mild psychological stress, which is strongly reflected in the nearly identical
pattern of GR binding capacity across both tissues in all the experimental groups.
Therefore, our results (in peripheral tissues) support the negative feedback
paradigm whereby increased corticosterone levels (due to stress) lead to
decreased binding capacity of the GR.
As explained before, some previous studies support the idea that chronic stress
leads to decreased levels and/or binding capacity of GR (Sapolsky et al., 1984;
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Alexandrova & Farkas, 1992; Nishimura et ai., 2004). Others believe that GR
levels and or binding capacity are either increased during chronic stress (AI-
Mohaisen et ai., 2000; Sun et ai., 2002) or remain the same (Svec et ai., 1989;
Lowy, 1991). We attempted to duplicate the methods of AI-Mohaisen et al. (AI-
Mohaisen et ai., 2000), without achieving any success. We thus remain skeptical
as to whether significant increases in GR binding capacity are measured after
exposure to chronic stress. More recent reports also support the down-regulation
of GRs, e.g. (1) decreased expression in neuronal GR in rats occurred following
intrathecal IL-6 antiserum administration after chronic stress (Wang et ai., 2004)
and (2) pro-inflammatory cytokines (TNF-a and IL-1P) in pathologically scalded
rats was shown to be involved in the down-regulation of GRs (Liu et ai., 2002).
These reports add further evidence that the down-regulation of GR expression
serves to moderate the effects of the stress response, which in itself could be
detrimental to the organism.
In addressing this discrepancy, another consideration will be evaluation of the
role of the GR in subsequent tissue responses. Due to energy demands of the
organism, the expression of TAT and GS enzymes need to be increased. Thus,
the role of GRs would be the activation of the GREs (and/or GRUs) in these
genes, which would ultimately result in increased breakdown of proteins (e.g.
muscle) for the subsequent release of alanine and glutamine. The production and
release of GCs from the adrenal lead to increased plasma levels of hormone,
which ultimately feeds back on the hypothalamus to release less CRH and
subsequently less ACTH. Thus, depending on the exact time during the stress
response at which the plasma and tissue samples were collected, one might
expect large differences in measured levels of both the GCs and GRs. This, in
part, may explain some of the discrepancies with regard to the different reports
regarding GR expression and/or binding capacity during stress states. However,
the activated GR-complex is involved in regulation of many other proteins and
enzymes, which adds to the list of complexities of the GC-GR system. Our
results clearly indicate decreased GR binding capacity. Measurement of GR
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expression levels were beyond the scope of this project and should be
considered in future interventions since it might shed additional valuable insight
into our understanding of this complex matter.
The enzyme activities (TAT and GS) increased in liver and skeletal muscle even
though the GR binding capacity decreased in both these tissues. This might
appear perplexing since GR is known to activate the GREs in the promoter
regions of the genes of these enzymes, and less GR should then lead to less
enzymatic activity. One explanation could lie in the fractional occupancy of GR.
The fractional occupancy is defined as the fraction of all receptors that are bound
to ligand (Motulsky, 1996).Algebraically, it is shown as follows:
. . [ligand]Fractional Occupancy = _;:_.=:._ _;:___
[ligand] + Kd
During stress, when the ligand (GCs) concentration is very high (many times ~,
the dissociation constant - an indicator of affinity between ligand and receptor, so
that the value of ~ in negligible), it's fractional occupancy of the receptor equals
1.00. This means that all available receptors are occupied, which may ultimately
have more GREs activated. During basal conditions, the ~ may be increased
(resulting in the GC ligand having a lower binding affinity to the GR), which leads
to a lower fractional occupancy. In short, increased enzymatic activities are
feasible even with decreased GR binding capacity because the fractional
occupancy of the GR by GCs is high during stress.
In addition to the effects of immobilisation stress, the IL-6-Ab treatment also led
to decreased binding capacity of GR in both the livers and skeletal muscles of
the animals. This is the first result of its kind in either liver or muscle tissue.
However, IL-6 has previously been shown to increase GR levels in cells of
Kaposi's sarcoma (Guo et aI., 1996), lymphoid (Rakasz et aI., 1993) and
osteoblast-like cells (Dovio et aI., 2001). In an additional study published by a
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group of neuroscientists, it was established that, in chronic neuropathic pain, a
causal relationship exists between elevated levels of spinal IL-6 and neuronal GR
expression (Wang et a/., 2004). Although it focuses on pain, the findings of this
study (together with those of the studies mentioned above) correlate well with the
data we present which indicate that IL-6 may up-regulate peripheral GR
expression during psychological stress. In addition, several lines of evidence
indicate that IL-6 and PKC playa prominent role in the expression of these
neuronal GRs. It remains to be shown whether PKC (with or without IL-6) may
mediate the same GR response in highly metabolically active peripheral tissues
after psychological stress. Our study is the first to indicate that the IL-6-Ab leads
to decreased levels of GR in vivo after psychological stress, since all the
examples mentioned before are based on in vitro work. Furthermore, the
reduction in GR binding capacity by the IL-6-Ab occurred with or without stress
(Figs 4.4A and 4.4B: CP vs. CA; lP vs. lA). These data suggest a normal function
of IL-6 is to maintain a basal level of GR binding capacity and in the face of
stress, to partially counteract the GC effect (Masera et a/., 2000).
The significant relationship measured between ~BM and GR binding capacity (in
both liver and skeletal muscle) is shown in Table 4.3. Since loss of body mass is
associated with increased levels of circulating corticosterone, GR binding
capacity is also associated with levels of GCs, which is concurrent with common
opinion regarding this matter. A new finding is that the ~BM correlated best with
GR binding capacity in the antibody group i.e. when a possible modulating effect
of IL-6was absent or at least diminished.
In many cases, tissue responsiveness to stress under specific experimental
conditions (e.g. psychological stress or inflammation) has focused on receptor
expression and subsequent enzyme activity. We specifically chose to study two
enzymes that were known to be under GC control, viz. TAT and GS. We were
particularly interested in whether neutralisation of IL-6 action could affect their
respective activity levels. The immobilisation stress caused increased enzymatic
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activities for both TAT and GS, in liver and muscle. However, it was only in the
liver that TAT activity was increased significantly more in response to stress in
the absence of IL-6. The latter implies that in the liver the presence of IL-6 can
on the one hand antagonize GC-mediated enzyme upregulation, and on the
other hand that there is a synergistic effect of IL-6 in downregulating the stress
response similar to the effect of stress on GR binding capacity. In support of
these results, a recent study has shown that IL-6c (a recombinant IL-6 molecule)
reduces TAT activity in fetal rat hepatOcytes (Zvibel et al., 2004). To our
knowledge, the latter is the only in vitro study to investigate TAT activity as a
marker of tissue responsiveness to treatment with IL-6 or its recombinant
analogues; and ours is the only in vivo study to indirectly assess the same thing
through blocking of IL-6 action. In summary (with regards to enzyme activity) the
effects of stress on protein catabolic activity were significant in liver and muscle,
whereas a significant effect of the antibody could only be measured in liver. It
remains to be seen if our study simply lacked the statistical power to show the
same result in muscle, or if the two tissues are indeed differently responsive in
this regard. In addition, the up-regulation of the protein catabolic enzymes is not
inconsistent with the down-regulation of GR binding capacity, if it is assumed that
total occupancy of GRs by GCs was higher under conditions of psychological
stress.
In terms of the correlation analysis performed, we calculated significant negative
relationships between ~BM and TAT activity in both the total group of rats and
the placebo group, but not in the antibody-treated group. This is interpreted to
mean that loss of body mass is inversely proportional to the activity of TAT in
liver and muscle. The lack of this relationship in the antibody-treated group is
perplexing, and might be related to differential activation of the TAT gene GRE in
the presence of the antibody. In the muscles, a relationship was observed
between the ~BM and GS, in the total ·group as well as the placebo- and
antibody-treated groups. The fact that the relationship holds between ~BM and
GS, but not ~BM and TAT, adds to this perplexing issue and further research is
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needed to clarify this finding especially since we did report a positive relationship
between the two enzymes' activities (Fig 4.7). Since these two enzymes have
quite different roles in the cascade of protein catabolism, they have not both
been investigated before in the same in vivo setting, but our interest was sparked
because metabolic regulation of protein metabolism may determine whether or
not an organism is capable of adapting successfully to chronic psychological
stressors.
As mentioned throughout the thesis, much work has been done in terms of
investigating HPA axis stimulation under various conditions, including acute
stimulation by IL-6 (Raber, et al., 1997). However, less is known about the
chronic effects of IL-6 on the function of the HPA axis. Therefore, the aim of the
next few paragraphs is to place the physiological significance of our study in
context with previous work in the field, in an attempt to add evidence to the
mechanism of peripheraIIL-6-induced stimulation of the HPA axis under basal as
well as stressed conditions.
In the rat, the sites in the the HPA axis where IL-6 could playa role in the stress
response are the hypothalamus (Loxley et al., 1991, 1993; Lyson et al., 1991;
Navarra et al., 1991; Lyson & McCann, 1992; Spinedi et al., 1992; Raber et al.,
1994; Yasin et al., 1994; Kageyama et al., 1995), the pituitary gland (Bateman et
al., 1989; Stephanou et al., 1992; Muramami et al., 1993; Sarlis et al., 1993) and
the adrenal gland (Muramami et al., 1993; Gonzalez-Hernandez et al., 1994). Rat
IL-6 mRNA is found in the anterior pituitary (Vankelecom et al., 1989; Spangelo
et al., 1990, 1994) and is increased with chronic stimulation of the HPA axis by
adjuvant injections (Stephanou et al., 1992). Furthermore, IL-6 mRNA at the level
of the anterior pituitary is under control of glucocorticoid feedback (SarIis et al.,
1993). IL-6 itself stimulates ACTH secretion under in vivo and in vitro conditions
(Bateman et al., 1989; Spangelo et al., 1994) whereas LPS activates the HPA
axis in rats with PVN lesions implying that CRF-independent mechanisms are
involved in the overall inflammatory response to LPS administration (Elenkovet
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aI., 1992). LPS also increases serum IL-6 levels and IL-6 mRNA in peripheral
organs (Schëbitz et al., 1993), suggesting that IL-6 may be the mediating
cytokine in the effects of LPS seen in the absence of the PYN . In summary,
these reports support a direct effect of IL-6 on the pituitary or extrapituitary non-
PYN pathways of HPA axis activation (Elenkovet al., 1992). In general, IL-6
seems to have a stimulating effect on the activity of the HPA axis.
In contrast, GCs are commonly known to have a suppressive effect on the HPA
axis (Cole et aI., 2000). It was shown that the synthetic GC, dexamethasone,
acts primarily on the GR in the anterior pituitary (Cole et aI., 2000), also that the
inhibitory effects of dexamethasone did not take place at the level of the adrenal
gland since the corticosterone response to an ACTH challenge was unaffected
by dexamethasone administration (Cole et aI., 2000). Therefore, it is fair to
conclude that circulating GCs generally attempt to inhibit HPA axis activity during
stress by downregulating their own receptors.
In terms of the metabolic tissues we investigated, the anti-IL-6-Ab seemed to
have similar effects, in different magnitudes, in both liver and skeletal muscle.
This is interesting since many previous reports concentrated on either one or the
other of these tissues and neglected to compare GR expression and/or enzyme
activities between these important metabolic 'engines'. In addition, our study is
the first in vivo study that investigates the peripheral metabolic effects of antil-IL-
6-Ab on GC action. IL-6 has been shown to increase GR levels in osteoblast
(Maseru et aI., 2000; Dovio et aI., 2001b), Kaposi's sarcoma (Guo et aI., 1996)
and lymphoid cells (Rakasz et aI., 1993). One in vivo study in rats focused on
central interaction between IL-6 and GR and found that IL-6 has a direct
stimulatory effect on neuronal GR levels (Wang et aI., 2004). We report that the
anti-IL-6-Ab decreases GR levels in the liver and skeletal muscle during mild
psychological stress, indicating that IL-6 promotes GR levels, in agreement with
the reports mentioned above.
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Again, it should be mentioned that measurements of IL-6 concentrations were
not obtained during the data collection process. This proves to be a handicap in
interpretation since there is no indication of whether the antibody succeeded in
neutralizing all IL-6 molecules. Results do indicate that the antibody succeeded
in preventing a full-blown corticosterone response in the rats, but this does not
prove in any way that IL-6 molecules have been bound by the antibody in
circulation. It is suggested that this approach be taken in a follow-up study, since
this would provide many insights into the role that IL-6 plays in modulation of GC
action in the periphery.
In terms of speculation with regards to the duration of adaptation observed in the
rats, the corticosterone levels are expected to normalize after a day or two after
the last bout of stress. Body weight levels correlate well with changes in
circulating GCs, thereby being expected to normalize within 3 days, permitted
that no other major form of extrinsic or intrinsic stress is applied. Enzymatic
activity levels are also expected to normalize within hours after removal of the
stressor, although regulation by GR activation may prolong this normalization.
Taken together, our results indicate an antagonistic relationship between IL-6
and glucocorticoids and confirm the presence of cross-talk. In colloquial terms,
IL-6 seems to act as the chemical inducer of a molecular brake on GC action
during stress. This is especially evident in the tissue responses of our rats: the
IL-6-Ab .further decreased GR levels and further increased enzymatic activity
(thus IL-6 itself would increase GR levels and decrease enzyme expression),
whereas GCs are known to decrease GR and increase both TAT and GS
activities (as explained in Chapter 2). Therefore, IL-6 may indeed be the key
cytokine agent that modulates the GC-mediated stress response in metabolic
tissues, .possibly in order to partially limit protein breakdown. Furthermore, we
suggest that IL-6 may both directly and indirectly influence enzymatic activity
levels. It has been mentioned before that IL-6 is thought to act as a hormone,
which supports the idea that it may exert direct effects on the activity of TAT in
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the liver. In terms of indirect effects, the cross-talk paradigm between GCs and
cytokines provide a basis for the suggestion that IL-6 may indeed modulate GC
action and due to this, indirectly affect the activity levels of GC-inducible
enzymes. In terms of the possible mechanisms as desribed in Fig 2.5, it is likely
that IL-6 may indeed bind to nGRE sites by ways of composite or tethering
mechanisms. It is also possible that IL-6 may compete with the other complexes
for binding to the nGRE (competitive nGRE, Fig 2.5) and thereby repress
activation of those enzymatic genes.
In conclusion, we confirm that protein breakdown occurs during chronic, mild
psychological stress (manifested by the decrease in body mass) and that this is
likely mostly due to protein catabolism mediated by the glucocorticoid system.
Our data provides the first in vivo evidence that an absence of IL-6 modulates
GC action, thus confirming the presence of cross-talk between the cytokine and
endocrine systems in metabolically active peripheral tissues. Specifically, we
show further down-regulation of both basal and stress-induced GR binding
capacity in metabolic target tissues in the absence of IL-6. In addition, we report
the first line of evidence to show that the activities of TAT and GS in mammalian
organisms are positively related in terms of their catabolic abilities, especially
under conditions of psychological stress.
This study has paved the way for further investigations into the peripheral
interactions between the cytokine and glucocorticoid systems. Firstly, a more
complete pattern of GR protein expression and distribution in peripheral
metabolic tissues needs to be determined after exposure to chronic
psychological stress. Knockout-mice and antibodies raised against cytokines
both remain valuable tools for determining the exact mechanisms of interaction
between endocrine and cytokine systems. However, use of antibodies holds the
advantage that acute interference of the normal physiology can be investigated.
In addition, this kind of research should encompass both central and peripheral
investigations, since it is known that many actions of cytokines are stimulated by
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interleukin-1 release in the central system. Importantly, it should be realised that
the stress response is mediated by psychological, immunological, neural and
endocrine systems as well as other target tissues, which should all be considered
when planning such experiments. An ideal follow-up study will determine tissue-
responses to different kinds of chronic stress, with biochemical and physiological
analyses of a combination of the levels of CRF, ACTH, corticosterone, IL-1, IL-6,
and GR In this way, the peripheral tissue-responses can directly be correlated
with central responses, which should provide a more holistic viewpoint of the
integrated stress response.
Finally, in the peripheral metabolically active tissue, it would be valuable to
attempt to ascertain the mechanism of IL-6 interference of GC action using
molecular techniques to determine whether or not IL-6 acts directly, or indirectly
on GRE's or GRU's.
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Appendix A
In this section, examples of calculations are shown for the different conversions
of the values (obtained from the spectrophotometer and radioactive counter) to
appropriate values. In all cases, the protein was diluted to a concentration of 2
mg/ml for muscle and 10 mg/ml for liver.
1. Glucocorticoid Receptor
The radioactive counter provides values in cpm (counts per minute). The table
below shows the stepwise conversion to the appropriate units (fmol/mg protein)
of one fictitious data point.
fmol/mg
protein
mol/mg
protein
DPM Ci mol
CPM
4123.4 11781.1 5.31E-09 6.394E-14 1.930E-15 1.9
CPM, counts per minute; OPM, disintegrations per minute; Ci, curie (measure of radioactivity)
2. Tyrosine Aminotransferase
The spectrophotometer provides absorbance values at a wavelength of 330 nm.
The table below shows the stepwise conversion to the appropriate units (U/mg
protein) of one fictitious data point. Three (3) absorbance values are obtained (10
minutes, 20 minutes, 30 minutes), from which a slope is determined (Absorbance
per minute). A molar extinction coefficient of 19 900 M-1cm-1 is used to convert
from absorbance values to molar units. One unit of enzyme activity is described
as the amount of enzyme needed to convert 1 umole of substrate per minute, at
37°C.
Abs/min A
0.025704 O.
3. Glut
The spectr
The table
(nmol/min/g
per sample.
f.1moles/hr/
f.1gprotein
U/f.1g
protein/hr
mU/mg
protein/hr
U/mg
protein/hr
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bs/min/f.1g M/hr/f.1g
protein protein
000390 0.00000000196 0.0000002 0.000000196 196.0 0.196
Abs, absorbance; hr, hour
amine Synthetase
ophotometer provides absorbance values at a wavelength of 540 nm.
below shows the stepwise conversion to the appropriate units
protein) of one fictitious data point. One endpoint value is obtained
The molar extinction coefficient used in the assay is 1.08 M-1cm-1.
Abs/mg M/mg M/min/mg
protein protein protein (nmol/min/mg protein)
0.678 0.628 0.025 5023.4
Activity
Abs
0.177
Abs, absorbance; min, minute
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Appendix B
For purposes of method validation, saturation binding curves and scatchard plots
were constructed. These analytical graphs are standard biochemical tools of
assessment that form the basis for comparison to work previously published.
1) Saturation binding curves
Saturation radioligand binding experiments measure specific radioligand binding
at equilibrium at various concentrations of the radioligand. Analysis of this data
allows one to determine receptor number and affinity. This kind of experiment is
commonly analysed with Scatchard plots (see next section), and are therefore
sometimes called "Scatchard experiments". The following graphs show data
obtained from two single experimental attempts in both muscle and liver.
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MUSCLE
concentration 3H-Dex
Appendix GraphA Saturation binding curve in skeletal muscle tissue
of a Wistar rat, showing data points from two separate experimental attempts
(blue vs. red). Different concentrations of tritiated dexamethasone was used as
radioligand and the measured binding capacity is expressed as fmol/mg protein.
Specific binding is calculated by subtracting non-specific binding from total
binding, as explained in Chapter 3 of this thesis.
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LIVER
concentration 3H-Dex
Appendix Graph B Saturation binding curve in hepatic tissue of a
Wistar rat, showing data points from two separate experimental attempts (blue
vs. red). Different concentrations of tritiated dexamethasone was used as
radioligand and the measured binding capacity is expressed as fmol/mg protein.
Specific binding is calculated by subtracting non-specific binding from total
binding, as explained in Chapter 3 of this thesis.
2) Scatchard Plots
Previously, scientists transformed non-linear data into a linear form, and then
analysed the data by linear regression. There are several ways to linearize
binding data, including the methods of Lineweaver-Burke and Eadie-Hofstee.
However, the most popular method to linearize binding data is to create a
Scatchard plot, shown in the panel below.
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In this plot, the X-axis is specific binding and the Y-axis is specific binding divided
by free radioligand concentration. It is possible to estimate the Bmax and Kd from a
Scatchard plot (Bmax is the X intercept; ~ is the negative reciprocal of the slope).
However, the Scatchard transformation distorts the experimental error, and thus
violates several assumptions of linear regression. The Bmax and ~ values
determined by linear regression of Scatchard transformed data may be far from
their true values.
The derived Scatchard plots of Appendix Graphs A and B are shown below, for
skeletal muscle and liver, respectively.
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Appendix Graph C Scatchard plot of binding data obtained from
skeletal muscle tissue of a Wistar rat. The blue and red data points distinguished
between data from two different experimental attempts. From this, the Bmax and
Kd values were determined to be 8.6 and 5.2 fmol/mg protein, respectively.
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Appendix Graph D Scatchard plot of binding data obtained from
hepatic tissue of a Wistar rat. The blue and red data points distinguished
between data from two different experimental attempts. From this, the Bmax and
~ values were determined to be 95.0 and 6.1 fmol/mg protein, respectively.
